<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">03587</article-id><article-id pub-id-type="doi">10.7554/eLife.03587</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Cell cycle constraints on capsulation and bacteriophage susceptibility</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-15021"><name><surname>Ardissone</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15022"><name><surname>Fumeaux</surname><given-names>Coralie</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-19193"><name><surname>Bergé</surname><given-names>Matthieu</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-19194"><name><surname>Beaussart</surname><given-names>Audrey</given-names></name><xref ref-type="aff" rid="aff2"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15024"><name><surname>Théraulaz</surname><given-names>Laurence</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15023"><name><surname>Radhakrishnan</surname><given-names>Sunish Kumar</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="pa1">†</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-19195"><name><surname>Dufrêne</surname><given-names>Yves F</given-names></name><xref ref-type="aff" rid="aff2"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-7149"><name><surname>Viollier</surname><given-names>Patrick H</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Microbiology and Molecular Medicine</institution>, <institution>Institute of Genetics and Genomics in Geneva, University of Geneva</institution>, <addr-line><named-content content-type="city">Geneva</named-content></addr-line>, <country>Switzerland</country></aff><aff id="aff2"><institution>Institute of Life Sciences, Université catholique de Louvain</institution>, <addr-line><named-content content-type="city">Louvain-la-Neuve</named-content></addr-line>, <country>Belgium</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Storz</surname><given-names>Gisela</given-names></name><role>Reviewing editor</role><aff><institution>National Institute of Child Health and Human Development</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>patrick.viollier@unige.ch</email></corresp><fn fn-type="present-address" id="pa1"><label>†</label><p>School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, Thiruvananthapuram, India</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>25</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>3</volume><elocation-id>e03587</elocation-id><history><date date-type="received"><day>04</day><month>06</month><year>2014</year></date><date date-type="accepted"><day>21</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>© 2014, Ardissone et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Ardissone et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-03587-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.03587.001</object-id><p>Despite the crucial role of bacterial capsules in pathogenesis, it is still unknown if systemic cues such as the cell cycle can control capsule biogenesis. In this study, we show that the capsule of the synchronizable model bacterium <italic>Caulobacter crescentus</italic> is cell cycle regulated and we unearth a bacterial transglutaminase homolog, HvyA, as restriction factor that prevents capsulation in G1-phase cells. This capsule protects cells from infection by a generalized transducing <italic>Caulobacter</italic> phage (φCr30), and the loss of HvyA confers insensitivity towards φCr30. Control of capsulation during the cell cycle could serve as a simple means to prevent steric hindrance of flagellar motility or to ensure that phage-mediated genetic exchange happens before the onset of DNA replication. Moreover, the multi-layered regulatory circuitry directing HvyA expression to G1-phase is conserved during evolution, and HvyA orthologues from related <italic>Sinorhizobia</italic> can prevent capsulation in <italic>Caulobacter</italic>, indicating that alpha-proteobacteria have retained HvyA activity.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.001">http://dx.doi.org/10.7554/eLife.03587.001</ext-link></p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.03587.002</object-id><title>eLife digest</title><p>Many bacteria have a tough outer coating known as capsule that protects them from untoward environmental conditions. This capsule also prevents viruses called bacteriophages from invading the bacterial cells, and it shields those bacteria that can infect humans from attack by our immune system. External conditions—such as a lack of nutrients and physical stresses—are known to trigger capsule formation. However, almost nothing is known about the signals from within the bacteria that control the formation of a capsule.</p><p>Now, Ardissone et al. have used the capsulated bacterium called <italic>Caulobacter crescentus</italic> to show that capsule formation is regulated by the bacterial cell cycle. This cycle is a series of events and checkpoints that happen every time a cell divides to form two new cells. Ardissone et al. revealed that capsule cannot form during the first phase of the cell cycle. The bacterium only forms its capsule as this phase ends and before it copies its DNA and later divides in two.</p><p>Ardissone et al. discovered that an enzyme called HvyA, which is only produced during the first phase of the cell cycle, prevents the capsule from forming. Inactivating the HvyA enzyme was also shown to make the bacteria impervious to infection by a bacteriophage. Furthermore, Ardissone et al. dissected the complicated steps involved in regulating the production of the HvyA enzyme and showed that such regulatory steps are also used by other species of bacteria.</p><p>Without their capsules, bacteria can take up new genetic material from a number of sources that might help them adapt to a changing environment. Ardissone et al.'s findings suggest that by only exchanging genetic material during the first phase of the cell cycle, bacteria ensure that any useful DNA is taken up and copied along with their own DNA later in the cell cycle.</p><p>Antibiotic resistance spreads between bacteria via the exchange of genetic material, making it increasingly difficult to treat bacterial infections. Interfering with the formation of the capsule during an infection could help overcome this problem by making the bacteria more vulnerable to attack either by our own immune system or by bacteriophages that can be used to treat bacterial infections. By investigating how genetic exchange and capsule formation are linked and regulated, the findings of Ardissone et al. might now open up new strategies to help combat bacterial infections.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.002">http://dx.doi.org/10.7554/eLife.03587.002</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author keywords</title><kwd>capsule</kwd><kwd>cell cycle</kwd><kwd>BTLCP</kwd><kwd>bacteriophage</kwd><kwd>generalized transduction</kwd><kwd><italic>Caulobacter crescentus</italic></kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Swiss National Science Foundation</institution></institution-wrap></funding-source><award-id>31003A_143660</award-id><principal-award-recipient><name><surname>Viollier</surname><given-names>Patrick H</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Synapsis Foundation</institution></institution-wrap></funding-source><award-id>Stammbach Stiftung A/C ME9175</award-id><principal-award-recipient><name><surname>Viollier</surname><given-names>Patrick H</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A multi-layered and conserved cell cycle mechanism prevents capsulation, long known as a bacterial virulence determinant, in G1-phase and concurrently licenses bacteriophage-mediated genetic exchange prior to entry into S-phase.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Genetic exchange is both fundamental to the adaptation of bacterial cells faced with ever-changing environmental conditions and the cause of the alarming dissemination of antibiotic resistance determinants among the bacterial pathogens. The underlying mechanisms include direct uptake of naked DNA (transformation) by bacterial cells as well as cell- or bacteriophage-based delivery systems (respectively conjugation and generalized transduction) (<xref ref-type="bibr" rid="bib77">Wiedenbeck and Cohan, 2011</xref>; <xref ref-type="bibr" rid="bib58">Seitz and Blokesch, 2013</xref>). Thus, uncovering mechanisms that curb genetic exchange could provide new entry points to help intervene with the spread of antibiotic resistances. While genetic exchange can be facilitated in response to changes in the number of cells in a population (quorum sensing) or other developmental states (<xref ref-type="bibr" rid="bib58">Seitz and Blokesch, 2013</xref>), an important but yet unresolved question is whether genetic exchange can also be regulated by systemic cues, such as those directing cell cycle progression. Recent cytological experiments provide evidence that components of the pneumococcal natural transformation (competence) machinery can be linked to cell division, at least spatially (<xref ref-type="bibr" rid="bib4">Bergé et al., 2013</xref>), hinting that unknown mechanisms may indeed restrict genetic exchange in time or in space during the progression of the cell division cycle. A myriad of events are coordinated with progression through the eukaryotic cell cycle, but our understanding of such mechanisms and the factors that constrain them during the bacterial cell cycle are sparse.</p><p>Microbial polysaccharidic capsules can also restrict bacteriophage-mediated genetic exchange. Typically, they mask bacteriophage receptor sites that are on or near the cell surface (<xref ref-type="bibr" rid="bib32">Hyman and Abedon, 2010</xref>). Moreover, capsules are virulence factors in many Gram-negative and Gram-positive species, as they provide immune evasion by shielding or camouflaging the targets of host immune cells that are located on the surface of bacterial cells (<xref ref-type="bibr" rid="bib57">Schneider et al., 2007</xref>; <xref ref-type="bibr" rid="bib35">Kadioglu et al., 2008</xref>).</p><p>While capsulation can be regulated by nutritional cues (<xref ref-type="bibr" rid="bib35">Kadioglu et al., 2008</xref>; <xref ref-type="bibr" rid="bib79">Yother, 2011</xref>), cell envelope stresses (<xref ref-type="bibr" rid="bib39">Laubacher and Ades, 2008</xref>) or physical cues (<xref ref-type="bibr" rid="bib62">Sledjeski and Gottesman, 1996</xref>; <xref ref-type="bibr" rid="bib69">Tschowri et al., 2009</xref>; <xref ref-type="bibr" rid="bib40">Loh et al., 2013</xref>), no systemic cues are currently known. As virulence regulators have recently been found to control bacterial cell cycle transcription (<xref ref-type="bibr" rid="bib25">Fumeaux et al., 2014</xref>), capsulation might also be regulated by the cell cycle. The synchronizable and capsulated alpha-proteobacterium <italic>Caulobacter crescentus</italic> (henceforth <italic>Caulobacter</italic>) is the pre-eminent model system for cell cycle studies (<xref ref-type="bibr" rid="bib55">Ravenscroft et al., 1991</xref>; <xref ref-type="bibr" rid="bib61">Skerker and Laub, 2004</xref>; <xref ref-type="bibr" rid="bib16">Curtis and Brun, 2010</xref>). It recently transpired that many of the emerging concepts of cell cycle control, and the underlying mechanisms such as those directing an asymmetric cell division (<xref ref-type="bibr" rid="bib30">Hallez et al., 2004</xref>), are also operational in other alpha-proteobacterial lineages (<xref ref-type="bibr" rid="bib36">Kobayashi et al., 2009</xref>; <xref ref-type="bibr" rid="bib8">Brilli et al., 2010</xref>; <xref ref-type="bibr" rid="bib1">Ardissone and Viollier, 2012</xref>; <xref ref-type="bibr" rid="bib48">Pini et al., 2013</xref>; <xref ref-type="bibr" rid="bib25">Fumeaux et al., 2014</xref>). In <italic>Caulobacter</italic> this asymmetric cell division yields a motile and piliated swarmer (SW) cell that is in a G1-arrested state and a sessile stalked (ST) cell that resides in S-phase (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). The cellular buoyancy of the latter is higher than the former, a feature that has been exploited for synchronization of <italic>Caulobacter</italic> populations (by density gradient centrifugation) (<xref ref-type="bibr" rid="bib23">Ely, 1991</xref>) for cell cycle studies. A vast number of transcripts are cell cycle-regulated in <italic>Caulobacter</italic> (<xref ref-type="bibr" rid="bib37">Laub et al., 2000</xref>) and in the alpha-proteobacterium <italic>Sinorhizobium meliloti</italic> (<xref ref-type="bibr" rid="bib18">De Nisco et al., 2014</xref>), a plant symbiont. Importantly, many transcripts of orthologous genes are cell cycle-regulated and this is in large part governed by the conserved and essential <underline>c</underline>ell cycle <underline>tr</underline>anscriptional regulator A (CtrA). CtrA activates transcription of many late S- and G1-phase genes that are repressed by the transcriptional regulators SciP or the MucR1/2 paralogs, respectively (<xref ref-type="bibr" rid="bib25">Fumeaux et al., 2014</xref>; <xref ref-type="bibr" rid="bib29">Gora et al., 2010</xref>; <xref ref-type="bibr" rid="bib66">Tan et al., 2010</xref>)<italic>.</italic> In addition to acting as a transcriptional activator, CtrA functions as a negative regulator of gene expression and DNA replication initiation by binding to the conserved 5′-TTAA-(N)<sub>7</sub>-TTAA-3′ motif (CtrA box) located in many <italic>Caulobacter</italic> and <italic>Sinorhizobium</italic> promoters (<xref ref-type="bibr" rid="bib37">Laub et al., 2000</xref>, <xref ref-type="bibr" rid="bib38">2002</xref>; <xref ref-type="bibr" rid="bib25">Fumeaux et al., 2014</xref>) and the <italic>Caulobacter</italic> origin of replication (<italic>Cori</italic>) (<xref ref-type="bibr" rid="bib51">Quon et al., 1998</xref>).<fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.03587.003</object-id><label>Figure 1.</label><caption><title>Capsulation of <italic>Caulobacter</italic> cells is cell cycle regulated.</title><p>(<bold>A</bold>) Schematic of the <italic>Caulobacter</italic> cell cycle and the regulatory interactions that determine the presence/absence of the capsule (in blue). Phosphorylated CtrA (CtrA∼P) and MucR1/2 control expression of <italic>hvyA</italic>. The antagonistic kinase/phosphatase pair, DivJ (yellow dot) and PleC (green dot), indirectly influences CtrA∼P and partitions with the stalked (ST) cell chamber or swarmer (SW) cell chamber, respectively. PleC promotes CtrA∼P accumulation in the SW cell. HvyA prevents encapsulation in SW cells. Pink denotes HvyA accumulation in the SW (G1) cell compartment. Light blue indicates the presence of the capsule in ST(S) and pre-divisional (PD) cells. (<bold>B</bold>) Schematic of cell buoyancy upon centrifugation on density gradient for <italic>WT Caulobacter</italic> cells (left). SW cells sediment in the lower band (‘heavy’, in pink) whereas ST and PD cells sediment in the upper band (‘light’, in blue). Δ<italic>pleC</italic> and Δ<italic>hvyA</italic> cells are ‘light’ due to the constitutive presence of capsule (middle). Upon transposon mutagenesis with <italic>himar1</italic> Tn, we isolated ‘heavy’ non-capsulated mutants by cell density centrifugation (right). (<bold>C</bold>) <italic>Caulobacter</italic> loci identified by the cell density screen. The upper panel represents the <italic>CCNA_00162-CCNA_00168</italic> locus and the lower panel the <italic>CCNA_03921-CCNA_00472</italic> locus on the mobile genetic element of <italic>Caulobacter</italic> NA1000. The fragment deleted for each in-frame deletion is indicated (Δ). Black triangles indicate Tn insertions obtained in the Δ<italic>pleC</italic> background and white triangles indicate Tn insertions obtained in the Δ<italic>hvyA</italic> background. <italic>CCNA_00166</italic> (<italic>hvyA</italic>) is shown in pink, and the genes hit by our buoyancy screen for ‘heavy’ mutants are in blue. The asterisks show the ORFs identified as essential by <xref ref-type="bibr" rid="bib14">Christen et al. (2011)</xref>. (<bold>D</bold>) Schematic of capsule polymerisation/export system based on the one for group 1 CPS in <italic>E. coli</italic> (<xref ref-type="bibr" rid="bib15">Collins and Derrick, 2007</xref>). Putative functions were attributed to <italic>Caulobacter</italic> proteins based on the homology and conserved domains. CCNA_03998, CCNA_00466, and CCNA_00469 are putative glycosyltransferases; PssY, PssZ, and HfsE are polyisoprenylphosphate hexose-1-phosphotransferases; CCNA_00467 is a putative flippase; CCNA_00165 and CCNA_00470 are polymerases; CCNA_00163 and CCNA_00167 have homology to the tyrosine autokinase Wzc and its phosphatase Wzb, respectively, that regulate polymerisation and export; CCNA_00168 is the putative outer membrane lipoprotein required for translocation of the polysaccharide across the outer membrane.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.003">http://dx.doi.org/10.7554/eLife.03587.003</ext-link></p></caption><graphic xlink:href="elife-03587-fig1-v1.tif"/></fig></p><p>Binding of CtrA to its target sites is stimulated 100-fold by phosphorylation of aspartate at position 51 (D51, CtrA∼P) (<xref ref-type="bibr" rid="bib59">Siam and Marczynski, 2000</xref>) through a complex phosphorelay that controls both abundance and phosphorylation of CtrA as a function of the cell cycle (<xref ref-type="bibr" rid="bib5">Biondi et al., 2006</xref>; <xref ref-type="bibr" rid="bib33">Iniesta et al., 2006</xref>). CtrA∼P is present in G1-phase, proteolyzed during the G1→S transition to permit replication initiation and re-accumulates later in S-phase (<xref ref-type="bibr" rid="bib19">Domian et al., 1997</xref>).</p><p>G1-phase transcription is also positively dependent on PleC (<xref ref-type="bibr" rid="bib74">Wang et al., 1993</xref>), a phosphatase that is sequestered to the SW cell pole at cell division (<xref ref-type="bibr" rid="bib75">Wheeler and Shapiro, 1999</xref>). While PleC also regulates the cellular buoyancy properties, the molecular basis has never been determined. In this study, we use suppressor genetics to unearth the <italic>Caulobacter</italic> capsule as determinant of the buoyancy trait and we identify HvyA, a member of the poorly characterized <underline>b</underline>acterial <underline>t</underline>ransglutaminase-<underline>l</underline>ike <underline>c</underline>ysteine <underline>p</underline>rotease (BTLCP) family, as a PleC-dependent negative regulator that is restricted to G1-phase to prevent capsulation at this time in the cell cycle. As the capsule protects <italic>Caulobacter</italic> cells from infection by the generalized transducing Caulophage φCr30 and no CRISPR/Cas (<underline>c</underline>lustered <underline>r</underline>egularly <underline>i</underline>nterspaced <underline>s</underline>hort <underline>p</underline>alindromic <underline>r</underline>epeats–<underline>C</underline>RISPR <underline>as</underline>sociated)-based adaptive immunity system to protect cells from invading genetic material is encoded in the <italic>Caulobacter</italic> genome (<xref ref-type="bibr" rid="bib42">Marks et al., 2010</xref>), HvyA is the first example of a factor restricting phage infection to a confined cell cycle phase.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>A putative capsule export machinery governs the buoyancy switch</title><p>The switch in cellular buoyancy in NA1000 (<italic>WT</italic>) <italic>Caulobacter</italic> cells is cell cycle-regulated, but the underlying regulatory mechanism is elusive. We used a developmental mutant (Δ<italic>pleC</italic>) as an entry point to identify the genetic determinants conferring the change in buoyancy. Density gradient centrifugation of a <italic>WT</italic> culture yields ST and PD cells with the characteristic high buoyancy (for simplicity, we refer to these cells as ‘light’) and SW cells with the characteristic low buoyancy (‘heavy’ cells, <xref ref-type="fig" rid="fig1">Figure 1B</xref>). As Δ<italic>pleC</italic> cells are exclusively ‘light’, we simply sought <italic>himar1</italic> transposon (Tn) insertions that render Δ<italic>pleC</italic> cells ‘heavy’ (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). After backcrossing such ‘heavy’ Δ<italic>pleC</italic>::Tn mutants, we mapped the Tn insertion sites to two loci (<xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p><p>The first locus (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, upper panel) encodes putative components of a group 1 (Wzy)-like capsular polysaccharide (CPS) export machinery, in which the saccharide precursors are first assembled on undecaprenol (Und∼P, black zigzag in <xref ref-type="fig" rid="fig1">Figure 1D</xref>) on the cytoplasmic membrane, flipped and assembled in the periplasm into a polymer that is then translocated across the outer membrane and anchored on the cell surface (<xref ref-type="bibr" rid="bib76">Whitfield, 2006</xref>). Tn insertions were found in the genes encoding a putative capsular polysaccharide biosynthesis lipoprotein (<italic>CCNA_00162</italic>), a Wzc-like chain length regulator/tyrosine kinase (<italic>CCNA_00163</italic>), a putative O-antigen polymerase/ligase (<italic>CCNA_00164</italic>), a putative Wzb-like metallophosphatase (<italic>CCNA_00167</italic>), and a Wza-like outer membrane translocon (<italic>CCNA_00168</italic>), all commonly associated with capsular export systems. No Tn insertions were found in the other two genes within this cluster, <italic>CCNA_00166</italic> and <italic>pssY</italic>. For the latter, this could be explained by a functional redundancy of <italic>pssY</italic> with the orthologs encoded by <italic>pssZ</italic> and <italic>hfsE</italic>, all encoding polyisoprenylphosphate hexose-1-phosphotransferases (<xref ref-type="bibr" rid="bib68">Toh et al., 2008</xref>). By contrast, <italic>CCNA_00166</italic> is predicted to encode a putative <underline>b</underline>acterial <underline>t</underline>ransglutaminase-<underline>l</underline>ike <underline>c</underline>ysteine <underline>p</underline>rotease (BTLCP) and we describe below that an in-frame deletion of <italic>CCNA_00166</italic> (Δ<italic>hvyA</italic> in <xref ref-type="fig" rid="fig1">Figure 1C</xref>) in <italic>WT</italic> cells resulted in ‘light’ cells, akin to Δ<italic>pleC</italic> cells. Consistent with the results from the Tn analysis, an in-frame deletion (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) in <italic>pssY</italic> did not render cells ‘heavy’. By contrast, deleting <italic>CCNA_00162</italic>, <italic>CCNA_00163</italic>, <italic>CCNA_00164,</italic> or Δ<italic>CCNA_00167</italic> gave rise to ‘heavy’ <italic>WT</italic> (and Δ<italic>pleC</italic>) cells (<xref ref-type="fig" rid="fig1">Figure 1C</xref> and <xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="supplementary-material" rid="SD2-data">Supplementary file 1</xref>). Moreover, complementation of Δ<italic>CCNA_00162</italic>, Δ<italic>CCNA_00163</italic>, Δ<italic>CCNA_00164</italic>, Δ<italic>CCNA_00167,</italic> or <italic>CCNA_00168</italic>::Tn mutant cells with a plasmid harbouring the corresponding gene under the control of the vanillate inducible promoter (P<sub><italic>van</italic></sub>) on a medium–copy number plasmid (pMT335 (<xref ref-type="bibr" rid="bib67">Thanbichler et al., 2007</xref>)) restored the <italic>WT</italic> buoyancy phenotype, showing that the ‘heavy’ phenotype is attributable to the loss of <italic>CCNA_00162</italic>, <italic>CCNA_00163</italic>, <italic>CCNA_00164</italic>, <italic>CCNA_00167,</italic> or <italic>CCNA_00168</italic> function (<xref ref-type="supplementary-material" rid="SD2-data">Supplementary file 1</xref>).<fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.03587.004</object-id><label>Figure 2.</label><caption><title>Capsulation affects buoyancy, mucoidy, and bacteriophage sensitivity.</title><p>(<bold>A</bold>) Sensitivity to bacteriophage φCr30 and buoyancy of <italic>Caulobacter WT</italic> (NA1000) and different mutant strains. Mutation in <italic>CCNA_00163</italic> or <italic>CCNA_00470</italic> restores sensitivity to φCr30 in Δ<italic>pleC</italic> and Δ<italic>hvyA</italic> mutant backgrounds. Δ<italic>pleC</italic>, Δ<italic>hvyA</italic>, and the double mutant Δ<italic>pleC</italic> Δ<italic>hvyA</italic> are ‘light’, whereas mutation in <italic>CCNA_00163</italic> or <italic>CCNA_00470</italic> renders cells ‘heavy’ (also in a Δ<italic>pleC</italic> or Δ<italic>hvyA</italic> background). (<bold>B</bold>) Mucoidy of <italic>Caulobacter WT</italic> (NA1000) and different mutant strains plated on PYE medium supplemented with 3% sucrose. <italic>WT</italic>, Δ<italic>pleC</italic>, and Δ<italic>hvyA</italic> are highly mucoid, whereas mutations in <italic>CCNA_00163</italic> or <italic>CCNA_00470</italic> confer a ‘rough’ non-mucoid phenotype in all three backgrounds (<italic>WT</italic>, Δ<italic>pleC</italic>, and Δ<italic>hvyA</italic>). (<bold>C</bold>) Mucoidy of <italic>Caulobacter WT</italic> (NA1000), Δ<italic>pleC</italic>, or Δ<italic>hvyA</italic> cells over-expressing <italic>hvyA</italic> under control of P<sub><italic>van</italic></sub> on a medium copy number plasmid (pMT335) or P<sub><italic>xyl</italic></sub> on a low copy number plasmid (pMT375). Over-expression of <italic>hvyA</italic> confers the typical non-mucoid ‘rough’ colony phenotype on PYE agar plates supplemented with 3% sucrose, while the WT, Δ<italic>pleC</italic>, and Δ<italic>hvyA</italic> cells have a mucoid ‘smooth’ colony appearance. Sensitivity to bacteriophage φCr30 and buoyancy of <italic>Caulobacter WT</italic> (NA1000), Δ<italic>hvyA</italic>, Δ<italic>pleC</italic>, and Δ<italic>mucR1/2</italic> strains carrying pMT335-<italic>hvyA</italic> or pMT375-<italic>hvyA</italic> are shown in <xref ref-type="fig" rid="fig2s1 fig2s2">Figure 2—figure supplement 1–2</xref>. RsaA extracted from the same <italic>Caulobacter</italic> strains shown in <xref ref-type="fig" rid="fig2">Figure 2</xref> is displayed in <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>. The effect of proteinase K treatment on CCNA_00168 in <italic>Caulobacter WT</italic>, Δ<italic>hvyA</italic>, and Δ<italic>CCNA_00163</italic> is shown in <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>. The effect of the Δ<italic>hvyA</italic> mutation on swarming motility of <italic>Caulobacter</italic> is shown in <xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5</xref>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.004">http://dx.doi.org/10.7554/eLife.03587.004</ext-link></p></caption><graphic xlink:href="elife-03587-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.005</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Over-expression of <italic>hvyA</italic> renders Δ<italic>pleC</italic> cells ‘heavy’ and sensitive to φCr30.</title><p>Sensitivity to φCr30 and buoyancy of <italic>C. crescentus WT</italic>, Δ<italic>pleC</italic> or Δ<italic>hvyA</italic> cells harbouring <italic>hvyA</italic> on plasmid, under control of P<sub><italic>van</italic></sub> (pMT335, medium copy number) or P<sub><italic>xyl</italic></sub> (pMT375, low copy number). Over-expression of <italic>hvyA</italic> restores sensitivity to φCr30 and ‘heavy’ cell buoyancy to the Δ<italic>pleC</italic> or Δ<italic>hvyA</italic> cells.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.005">http://dx.doi.org/10.7554/eLife.03587.005</ext-link></p></caption><graphic xlink:href="elife-03587-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.006</object-id><label>Figure 2—figure supplement 2.</label><caption><title>Over-expression of <italic>hvyA</italic> renders Δ<italic>mucR1/2</italic> cells ‘heavy’. Buoyancy of Δ<italic>mucR1/R2</italic> cells harbouring <italic>hvyA</italic> on plasmid.</title><p>Over-expression of <italic>hvyA</italic> from P<sub><italic>van</italic></sub> or P<sub><italic>xyl</italic></sub> restores the ‘heavy’ phenotype to Δ<italic>mucR1/R2</italic> cells.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.006">http://dx.doi.org/10.7554/eLife.03587.006</ext-link></p></caption><graphic xlink:href="elife-03587-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.007</object-id><label>Figure 2—figure supplement 3.</label><caption><title>S-layer is correctly assembled in <italic>Caulobacter</italic> mutants affected in capsule production.</title><p>(<bold>A</bold>) RsaA, the main component of <italic>Caulobacter</italic> S-layer, is present in mutants affected in capsule synthesis/export. RsaA was extracted by EGTA treatment and run on 7.5% SDS-PAGE, followed by Coomassie staining. Mutations in <italic>pleC</italic>, <italic>hvyA</italic>, or <italic>CCNA_00163</italic> do not affect the presence of RsaA. Molecular size standards are indicated in blue on the left, with the corresponding values in kDa. RsaA is indicated by the arrowhead on the right. (<bold>B</bold>) The amount of RsaA extracted by EGTA treatment is not affected by <italic>hvyA</italic> over-expression or in mutants affected in capsule synthesis/export. Proteins extracted by EGTA treatment were run on 7.5% SDS-PAGE, followed by Coomassie staining. Molecular size standards are indicated in blue on the right, with the corresponding values in kDa. RsaA is indicated by the arrowhead on the left.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.007">http://dx.doi.org/10.7554/eLife.03587.007</ext-link></p></caption><graphic xlink:href="elife-03587-fig2-figsupp3-v1.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.008</object-id><label>Figure 2—figure supplement 4.</label><caption><title>Capsule protects cell surface proteins from proteinase K treatment.</title><p>Immunoblot anti-CCNA_00168 (outer membrane protein) on whole cells (<italic>WT</italic>, Δ<italic>hvyA</italic>, or Δ<italic>CCNA_00163</italic>) treated with proteinase K. Samples were taken at different time points (0, 15, 30, 45, and 60 min) after adding proteinase K. The immunoblot shows that CCNA_00168 is degraded by proteinase K more rapidly in the non-capsulated Δ<italic>CCNA_</italic>00163 mutant than in <italic>WT</italic> or Δ<italic>hvyA</italic> cells. This indicates that the absence of the capsule in the Δ<italic>CCNA_00163</italic> mutant strain makes the proteins in the outer membrane more accessible to proteinase K. Molecular size standards are indicated in blue on the left, with the corresponding values in kDa.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.008">http://dx.doi.org/10.7554/eLife.03587.008</ext-link></p></caption><graphic xlink:href="elife-03587-fig2-figsupp4-v1.tif"/></fig><fig id="fig2s5" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.009</object-id><label>Figure 2—figure supplement 5.</label><caption><title>Loss of <italic>hvyA</italic> affects swarming motility.</title><p>Δ<italic>hvyA</italic> cells show a motility defect on soft agar plate (PYE supplemented with 0.3% agar). We hypothesize that encapsulation of SW cells in the Δ<italic>hvyA</italic> mutant could interfere with flagellar rotation, as mutation of Δ<italic>CCNA_00167</italic> restores WT motility to the Δ<italic>hvyA</italic> cells.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.009">http://dx.doi.org/10.7554/eLife.03587.009</ext-link></p></caption><graphic xlink:href="elife-03587-fig2-figsupp5-v1.tif"/></fig></fig-group></p><p>The second cluster of genes resides on a 26-kbp <underline>m</underline>obile <underline>g</underline>enetic <underline>e</underline>lement (MGE) that has previously been implicated in buoyancy (<xref ref-type="bibr" rid="bib42">Marks et al., 2010</xref>) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, lower panel). Specifically, we recovered Tn insertions in genes predicted to encode a homolog of the putative N-acetyl-L-fucosamine transferase WbuB from <italic>E. coli</italic> that is involved in O-antigen (O26) synthesis (<xref ref-type="bibr" rid="bib20">D'Souza et al., 2002</xref>) (<italic>CCNA_03998</italic>), a polysaccharide polymerase (<italic>CCNA_00470</italic>) and a GDP-L-fucose synthase (<italic>CCNA_00471</italic>). The three genes are near other coding sequences for polysaccharides biosynthesis proteins, including two other putative glycosyltransferases (<italic>CCNA_00466</italic> and <italic>CCNA_00469</italic>), a Wzx-like polysaccharide flippase/translocase (<italic>CCNA_00467</italic>) and a sugar mutase homolog (<italic>CCNA_00465</italic>) (<xref ref-type="bibr" rid="bib42">Marks et al., 2010</xref>). Consistent with a previous genome-wide Tn analysis showing that these genes cannot be disrupted (<xref ref-type="bibr" rid="bib14">Christen et al., 2011</xref>), we were unable to engineer in-frame deletions in <italic>CCNA_00466</italic> or <italic>CCNA_00467</italic> in the absence of a complementing plasmid. As the entire 26-kb MGE is dispensable for viability, it appears that inactivation of either one of these four genes results in synthetic toxicity due to a polysaccharide intermediate or the sequestration of Und∼P that is also required for peptidoglycan synthesis (<xref ref-type="bibr" rid="bib79">Yother, 2011</xref>). To confirm that <italic>CCNA_03998</italic>, <italic>CCNA_00470</italic>, and <italic>CCNA_00471</italic> are indeed buoyancy determinants, we engineered in-frame deletions in <italic>CCNA_03998</italic> or <italic>CCNA_00470</italic> (<italic>CCNA_00471</italic> was not tested) in <italic>WT</italic> or Δ<italic>pleC</italic> mutant cells and found the resulting single or double mutants to be ‘heavy’ (<xref ref-type="fig" rid="fig1 fig2">Figures 1C and 2A</xref>, <xref ref-type="supplementary-material" rid="SD2-data">Supplementary file 1</xref>).</p><p>The association of the ‘heavy’ phenotype with a capsule synthesis and/or export defect, the resemblance of <italic>CCNA_03998</italic> to the predicted N-acetyl-L-fucosamine transferase WbuB (<xref ref-type="bibr" rid="bib20">D'Souza et al., 2002</xref>) and the fact that D-fucose is a known component of the extracellular polysaccharide or capsule of <italic>C. crescentus</italic> (<xref ref-type="bibr" rid="bib55">Ravenscroft et al., 1991</xref>) prompted us to test if these mutations also affected colony mucoidy, a phenotype typically associated with the presence of capsule or exopolysaccharides. Indeed, all ‘heavy’ mutants exhibited a non-mucoid (‘rough’) colony phenotype on PYE agar plates supplemented with 3% sucrose, while the <italic>WT</italic> or ‘light’ mutants (Δ<italic>pleC)</italic> had a mucoid (‘smooth’) colony appearance (<xref ref-type="fig" rid="fig2">Figure 2A,B</xref>, <xref ref-type="supplementary-material" rid="SD2-data">Supplementary file 1</xref>). In support of this result, we purified capsule from <italic>WT Caulobacter</italic>, Δ<italic>CCNA_00163</italic> (‘heavy’ and ‘rough’), Δ<italic>CCNA_00166</italic> (Δ<italic>hvyA</italic>, ‘light’ and ‘smooth’), and Δ<italic>hvyA</italic> Δ<italic>CCNA_00163</italic> (‘heavy’ and ‘rough’, see below) cells. As the <italic>Caulobacter</italic> capsule is primarily composed of neutral monosaccharides including fucose, mannose, galactose, and glucose (<xref ref-type="bibr" rid="bib55">Ravenscroft et al., 1991</xref>), we used glycosyl compositional analysis as proxy to quantify capsular material from ‘heavy’ and ‘light’ strains (See ‘Materials and methods’). As shown in <xref ref-type="table" rid="tbl1">Table 1</xref>, the expected sugars (determined as % of total carbohydrate weight in the preparations) were abundant in preparations from the <italic>WT</italic> and the ‘light’ mutant (Δ<italic>hvyA</italic>, <xref ref-type="table" rid="tbl1">Table 1</xref><italic>),</italic> whereas those from the ‘heavy’ mutants (i.e. the Δ<italic>CCNA_00163</italic> single mutant and the Δ<italic>hvyA</italic> Δ<italic>CCNA_00163</italic> double mutant) contained far less fucose, galactose, and mannose (up to 37-fold, 23-fold, and 5.5-fold reductions, respectively, in the Δ<italic>hvyA</italic> Δ<italic>CCNA_00163</italic> double mutant compared to the Δ<italic>hvyA</italic> single mutant). We also observed a significant reduction in galacturonic acid in the preparations from the ‘heavy’ mutants vs <italic>WT</italic> or ‘light’ cells<italic>,</italic> raising the possibility that this saccharide is also a constituent of the NA1000 capsule (<xref ref-type="table" rid="tbl1">Table 1</xref>).<table-wrap id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.03587.010</object-id><label>Table 1.</label><caption><p>Glycosyl composition of per-<italic>O</italic>-trimethylsilyl (TMS) derivatives of methyl glycosides performed on purified capsular polysaccharides from <italic>WT Caulobacter</italic> (NA1000), the single mutants Δ<italic>CCNA_00166</italic> (Δ<italic>hvyA</italic>) and Δ<italic>CCNA_00163</italic> and the Δ<italic>hvyA</italic> Δ<italic>CCNA_00163</italic> double mutant</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.010">http://dx.doi.org/10.7554/eLife.03587.010</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th align="center" colspan="2">NA1000</th><th align="center" colspan="2">Δ<italic>hvyA</italic></th><th align="center" colspan="2">Δ<italic>CCNA_00163</italic></th><th align="center" colspan="2">Δ<italic>hvyA</italic> Δ<italic>CCNA_00163</italic></th></tr><tr><th align="center">Glycosyl residue</th><th align="center">Mass (μg)</th><th align="center">Weight (%)</th><th align="center">Mass (μg)</th><th align="center">Weight (%)</th><th align="center">Mass (μg)</th><th align="center">Weight (%)</th><th align="center">Mass (μg)</th><th align="center">Weight (%)</th></tr></thead><tbody><tr><td align="center">Ribose</td><td align="center">0.8</td><td align="center">0.4</td><td align="center">0.1</td><td align="center">0.1</td><td align="center">0.3</td><td align="center">0.3</td><td align="center">0.5</td><td align="center">0.8</td></tr><tr><td align="center">Rhamnose</td><td align="center">2.3</td><td align="center">1.2</td><td align="center">1.1</td><td align="center">0.6</td><td align="center">6.4</td><td align="center">6.2</td><td align="center">2.7</td><td align="center">4.3</td></tr><tr><td align="center">Fucose</td><td align="center">19.8</td><td align="center">10.3</td><td align="center">26.5</td><td align="center">14.7</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">0.2</td><td align="center">0.4</td></tr><tr><td align="center">Xylose</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">0.1</td><td align="center">0.1</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">0.0</td></tr><tr><td align="center">Glucuronic Acid</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">0.8</td><td align="center">0.8</td><td align="center">0.3</td><td align="center">0.5</td></tr><tr><td align="center">Galacturonic acid</td><td align="center">28.4</td><td align="center">14.9</td><td align="center">32.6</td><td align="center">18.1</td><td align="center">5.6</td><td align="center">5.4</td><td align="center">2.3</td><td align="center">3.7</td></tr><tr><td align="center">Mannose</td><td align="center">23.2</td><td align="center">12.1</td><td align="center">26.6</td><td align="center">14.8</td><td align="center">3.9</td><td align="center">3.8</td><td align="center">1.7</td><td align="center">2.7</td></tr><tr><td align="center">Galactose</td><td align="center">30.1</td><td align="center">15.7</td><td align="center">37.0</td><td align="center">20.6</td><td align="center">1.4</td><td align="center">1.4</td><td align="center">0.5</td><td align="center">0.9</td></tr><tr><td align="center">Glucose</td><td align="center">64.3</td><td align="center">33.6</td><td align="center">52.9</td><td align="center">29.4</td><td align="center">49.9</td><td align="center">48.5</td><td align="center">23.7</td><td align="center">38.3</td></tr><tr><td align="center">N-Acetyl galactosamine</td><td align="center">2.0</td><td align="center">1.1</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">2.3</td><td align="center">2.2</td><td align="center">1.0</td><td align="center">1.7</td></tr><tr><td align="center">N-Acetyl glucosamine</td><td align="center">16.0</td><td align="center">8.4</td><td align="center">3.0</td><td align="center">1.6</td><td align="center">29.5</td><td align="center">28.7</td><td align="center">27.9</td><td align="center">45.2</td></tr><tr><td align="center">N-Acetyl mannosamine</td><td align="center">4.1</td><td align="center">2.2</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">2.2</td><td align="center">2.1</td><td align="center">0.7</td><td align="center">1.2</td></tr><tr><td align="center">Σ=</td><td align="center">191.3</td><td/><td align="center">179.9</td><td/><td align="center">102.8</td><td/><td align="center">61.8</td><td/></tr></tbody></table><table-wrap-foot><fn><p>Mass is expressed in μg and weight % is relative to the total carbohydrate.</p></fn></table-wrap-foot></table-wrap></p><p>Taken together, our results show that the loss of capsule synthesis and/or export renders cells ‘heavy’ and ‘rough’ and that the loss of capsulation is epistatic to the loss of PleC in buoyancy control. On these grounds we predicted that PleC, directly or indirectly, regulates one of the newly identified buoyancy determinants.</p></sec><sec id="s2-2"><title>Negative control of encapsulation by the transglutaminase homolog HvyA</title><p>Since the buoyancy switch is cell cycle-regulated and since all Δ<italic>pleC</italic> cells are ‘light’ (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), we reasoned that PleC is required to turn off capsule synthesis in G1-phase SW cells. As PleC is also required to activate motility and PilA (the structural subunit of the pilus filament) expression, when Δ<italic>pleC</italic> divides two daughter cells that are capsulated, non-piliated and non-motile are formed. By contrast division of <italic>WT</italic> yields one piliated, motile, and non-capsulated (‘heavy’) G1-phase SW progeny and one capsulated (‘light’) S-phase ST cell (<xref ref-type="fig" rid="fig1">Figure 1B</xref>).</p><p>If PleC indeed restricts capsulation temporally, it might control expression of a negative regulator of capsulation. Interestingly, PleC is required for the accumulation of the transcript of <italic>CCNA_00166</italic> (referred to as <italic>hvyA</italic> due to its requirement to render cells ‘heavy’) (<xref ref-type="bibr" rid="bib13">Chen et al., 2006</xref>). The <italic>hvyA</italic> transcript peaks during the G1-phase and encodes a 272-residue protein (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) harbouring a classical N-terminal Sec-dependent <underline>s</underline>ignal <underline>s</underline>equence (SS), but lacking discernible hydrophobic sequences or a lipidation signal for retention in the membrane, suggesting that it is periplasmic. The C-terminal part of HvyA features a BTLCP domain. This domain is thought to introduce intra- or inter-molecular crosslinks by transamidation, forming γ-glutamyl-ε-lysine isopeptide bonds between Gln and Lys residues, to hydrolyse amide bonds by the reverse protease reaction and/or to execute deamidation/esterification reactions of glutamine residues (<xref ref-type="bibr" rid="bib41">Lorand and Graham, 2003</xref>; <xref ref-type="bibr" rid="bib27">Ginalski et al., 2004</xref>). Cysteine proteases typically feature a Cys-His-Asp catalytic triad (C192, H226, and D241 for HvyA, based on sequence alignment, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) for the formation of a thioester bond intermediate by the reaction of the active site thiol (from the Cys) with Gln, followed by the transfer of the acyl group to an amine substrate (from the Lys) (<xref ref-type="bibr" rid="bib41">Lorand and Graham, 2003</xref>). As an in-frame deletion in <italic>hvyA</italic> (Δ<italic>hvyA</italic>) phenocopied the buoyancy defect of Δ<italic>pleC</italic> cells (yielding exclusively ‘light’ mucoid cells, <xref ref-type="fig" rid="fig1 fig2">Figures 1b, 2a, 2b</xref>), we conclude that HvyA is required for capsule-mediated buoyancy control in <italic>Caulobacter</italic>. While expression of <italic>WT</italic> HvyA from P<sub><italic>van</italic></sub> (pMT335-<italic>hvyA</italic>) reversed the buoyancy defect of Δ<italic>hvyA</italic> and Δ<italic>pleC</italic> cells, analogous plasmids encoding the predicted catalytic mutants (C192S/A, H226Q/A, or D241A) were unable to do so, although all the HvyA variants accumulated to comparable steady-state levels as the <italic>WT</italic> protein on immunoblots (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Thus expression of catalytically active HvyA is necessary and sufficient to mitigate the buoyancy defect of Δ<italic>pleC</italic> cells. As a genetic selection for ‘heavy’ Δ<italic>hvyA</italic>::Tn mutants was answered by Tn insertions in the same genes that render Δ<italic>pleC</italic> cells ‘heavy’ (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), we reasoned that mutations in capsule synthesis and export genes are epistatic to both the Δ<italic>hvyA</italic> and Δ<italic>pleC</italic> mutations. To confirm this notion, we engineered Δ<italic>hvyA</italic> Δ<italic>CCNA_00163,</italic> Δ<italic>hvyA</italic> Δ<italic>CCNA_00167,</italic> and Δ<italic>hvyA</italic> Δ<italic>CCNA_00470</italic> double mutants as well as a Δ<italic>pleC</italic> Δ<italic>hvyA</italic> Δ<italic>CCNA_00167</italic> triple mutant and found all resulting mutants to be ‘heavy’ and non-mucoid (‘rough’) on PYE sucrose plates (<xref ref-type="fig" rid="fig2">Figure 2A, B</xref> and <xref ref-type="supplementary-material" rid="SD2-data">Supplementary File 1</xref>). Importantly, constitutive expression of HvyA (from a P<sub>van</sub>- or a P<sub>xyl</sub>-plasmid) in <italic>WT</italic>, Δ<italic>pleC,</italic> or Δ<italic>hvyA</italic> cells also renders cells ‘heavy’ and ‘rough’ (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). On the basis of these findings we hypothesized that HvyA is a G1-specific negative regulator of capsulation whose expression is dependent on PleC (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).<fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.03587.011</object-id><label>Figure 3.</label><caption><title>HvyA is a <underline>b</underline>acterial <underline>t</underline>ransglutaminase-<underline>l</underline>ike <underline>c</underline>ysteine <underline>p</underline>rotease (BTLCP) homologue and its catalytic activity is required for function.</title><p>(<bold>A</bold>) Schematic of HvyA domains: signal sequence (SS) and BTLCP domain (in red) are indicated. C192, H226, and D241 constitute the putative catalytic triad (C192S/A, H226Q/A, and D241A alleles are non-functional; the D241N allele is functional, consistently with some BTLCP family members having a C/H/N catalytic triad). Residues identified in the buoyancy screen for non-functional variants are indicated below (blue, non-functional; green, partially functional). (<bold>B</bold>) Schematic of the buoyancy screen for HvyA non-functional variants. The P<sub><italic>van</italic></sub>-<italic>hvyA::TAP</italic> fusion (on plasmid) was subjected to random mutagenesis, then introduced into <italic>Caulobacter</italic> cells that were subjected to multiple rounds of enrichment for ‘light’ phenotype by centrifugation on density gradient. (<bold>C</bold>) Immunoblot anti-HvyA-TAP on periplasmic proteins extracted by EGTA treatment. The HvyA alleles mutated in putative catalytic residues are expressed and exported to the periplasm like the WT protein. Immunoblot against <italic>Caulobacter</italic> β-lactamase (CCNA_02223, Bla on the lower panel) is a control for periplasmic proteins. Molecular size standards are indicated in blue on the left, with the corresponding values in kDa. (<bold>D</bold>) Δ<italic>hvyA</italic> strains harbouring <italic>hvyA</italic> catalytic mutants under control of P<sub><italic>van</italic></sub> on plasmid were tested for sensitivity to φCr30. Over-expression of the C192S or H226Q alleles does not restore sensitivity to φCr30, indicating that these alleles are non-functional. (<bold>E</bold>) Immunoblot anti-HvyA-TAP on Δ<italic>hvyA</italic> cells harbouring mutagenized P<sub><italic>van</italic></sub><italic>-hvyA-TAP</italic> and selected for ‘light’ buoyancy. The P<sub><italic>van</italic></sub>-HvyA-TAP mutant alleles selected are still over-expressed. Molecular size standards are indicated in blue on the left, with the corresponding values in kDa. (<bold>F</bold>) Immunoblot anti-HvyA-TAP on EGTA fractions of the same clones shown in panel (<bold>E</bold>). The HvyA-TAP mutant alleles selected are exported to the periplasm like WT HvyA-TAP. Molecular size standards are indicated in blue on the left, with the corresponding values in kDa. (<bold>G</bold>) Δ<italic>hvyA</italic> strains harbouring <italic>hvyA</italic> variants under control of P<sub><italic>van</italic></sub> on pMT335 were tested for sensitivity to φCr30. The L240R, H226Y, and W178S alleles do not restore sensitivity to φCr30, whereas the P263R, R161P and D194G variants partially restore sensitivity to φCr30. The alignment of BTLCPs protein sequences from <italic>Caulobacter</italic> (HvyA), <italic>S. meliloti</italic> (SMc00998), <italic>S. fredii</italic> NGR234 (NGR_c12490), and <italic>P. fluorescens</italic> (PFL_0130) is shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. Immunoblots against HvyA-TAP, CtrA, and β-lactamase on whole lysates and EGTA fractions of cells expressing HvyA point mutants are shown in <xref ref-type="fig" rid="fig3s2 fig3s3">Figure 3—figure supplement 2–3</xref>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.011">http://dx.doi.org/10.7554/eLife.03587.011</ext-link></p></caption><graphic xlink:href="elife-03587-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.012</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Conservation of the BTLCP domain in HvyA orthologs.</title><p>Alignment of protein sequences for members of the BTLCP family. CAUCN, <italic>C. crescentus</italic> HvyA; RHIME, <italic>S. meliloti</italic> SMc00998; RHISN, <italic>S. fredii</italic> NGR_c12490; PSEF5, <italic>P. fluorescens</italic> PFL_0130. The three putative catalytic residues are indicated in red. The residues identified by our buoyancy screen for HvyA loss-of-function are indicated in blue (non-functional) and green (partially functional) above the sequence.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.012">http://dx.doi.org/10.7554/eLife.03587.012</ext-link></p></caption><graphic xlink:href="elife-03587-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.013</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Catalytic HvyA-TAP mutants are still exported to the periplasm.</title><p>Immunoblots on total proteins (right) and EGTA fractions (left) of Δ<italic>hvyA</italic> cells harbouring P<italic>van</italic>-<italic>hvyA-TAP</italic> derivatives on plasmid (WT or catalytic mutants). All the variants tested were produced and exported to the periplasm. Immunoblot anti-CCNA_02223 (β-lactamase, Bla) was used as control for the periplasmic proteins and immunoblot anti-CtrA as control for cytoplasmic proteins. Molecular size standards are indicated in blue on the right, with the corresponding values in kDa.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.013">http://dx.doi.org/10.7554/eLife.03587.013</ext-link></p></caption><graphic xlink:href="elife-03587-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.014</object-id><label>Figure 3—figure supplement 3.</label><caption><title>Over-expression of HvyA-TAP alleles.</title><p>(<bold>A</bold>) Immunoblot anti-HvyA-TAP on <italic>WT</italic> and Δ<italic>hvyA</italic> cells harbouring mutagenized P<sub><italic>van</italic></sub>-<italic>hvyA-TAP</italic> derivatives on plasmid. Mutagenized P<sub><italic>van</italic></sub>-<italic>hvyA-TAP</italic> was introduced in <italic>WT</italic> or the Δ<italic>hvyA</italic> strain and ‘light’ cells were selected by centrifugation on density gradient. ‘Light’ clones were tested by immunoblot in order to verify that the HvyA-TAP fusion was still expressed. The clones indicated by arrows were selected for sequencing the <italic>hvyA-TAP</italic> and identify the mutations. Cells harbouring <italic>WT</italic> P<sub><italic>van</italic></sub>-<italic>hvyA-TAP</italic> were used as control (C+) for the immunoblot. Molecular size standards are indicated in blue on the right, with the corresponding values in kDa. (<bold>B</bold>) Immunoblot anti-CtrA on EGTA fractions of Δ<italic>hvyA</italic> cells harbouring P<sub><italic>van</italic></sub>-<italic>hvyA-TAP</italic> derivatives on plasmid (WT or mutants). CtrA is a cytoplasmic protein and it is not released by EGTA treatment. The samples shown in this immunoblot are the same shown in <xref ref-type="fig" rid="fig3">Figure 3F</xref>. Molecular size standards are indicated in blue on the right, with the corresponding values in kDa.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.014">http://dx.doi.org/10.7554/eLife.03587.014</ext-link></p></caption><graphic xlink:href="elife-03587-fig3-figsupp3-v1.tif"/></fig></fig-group></p></sec><sec id="s2-3"><title>Microscopic visualization of the capsule</title><p>As all previous efforts to visualize the capsule directly by light or electron microscopy had been unsuccessful (<xref ref-type="bibr" rid="bib55">Ravenscroft et al., 1991</xref>), we conducted negative stain fluorescence microscopy (FM) with fluorescein isothiocyanate (FITC)-coupled dextran to measure the zone of exclusion of FITC-dextran in capsulated (Δ<italic>hvyA</italic>, ‘light’ mucoid) and non-capsulated (Δ<italic>CCNA_00163</italic>, ‘heavy’ non-mucoid) cells (<xref ref-type="fig" rid="fig4">Figure 4A,B</xref>). Akin to the difference between capsulated and non-capsulated <italic>Streptococcus pneumoniae</italic> (<xref ref-type="bibr" rid="bib31">Hathaway et al, 2012</xref>; <xref ref-type="bibr" rid="bib56">Schaffner et al, 2014</xref>), the zone of exclusion of FITC-dextran was significantly smaller in the case of Δ<italic>CCNA_00163</italic> compared to Δ<italic>hvyA</italic> cells, although the actual size of the cells by differential interference contrast (DIC) microscopy was comparable (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The increase in the exclusion radius of the dextran polymer can be explained by the presence of a capsule on Δ<italic>hvyA</italic> cells and by its absence from Δ<italic>CCNA_00163</italic> cells. Atomic force microscopy (AFM) (<xref ref-type="bibr" rid="bib21">Dufrêne, 2014</xref>) provided additional support for this interpretation. In these experiments, bacteria were immobilized on porous membranes, a method allowing AFM imaging of the bacteria in liquid medium. However, recording reliable images of live cells turned out to be very difficult for two reasons: (i) most cells were detached or pushed aside during scanning; (ii) strong interactions between the tip and the soft bacterial surface led to fuzzy images that were difficult to interpret. Therefore, cells were imaged after fixation with 4% paraformaldehyde, a protocol that is known to preserve cellular structures (<xref ref-type="bibr" rid="bib10">Chao and Zhang, 2011</xref>). <xref ref-type="fig" rid="fig5">Figure 5A–D</xref> shows representative low-resolution deflection images of fixed cells from the Δ<italic>CCNA_00163</italic> and Δ<italic>hvyA</italic> strains (from two independent preparations for each). As opposed to Δ<italic>CCNA_00163</italic> cells, which were readily imaged without apparent cell surface damage (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5">Figure 5C</xref>), the surface morphology of Δ<italic>hvyA</italic> cells (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, <xref ref-type="fig" rid="fig5">Figure 5D</xref>) was strongly altered by the scanning tip, and showed streaks in the scanning direction, reflecting strong interactions between the tip and the soft cell surface. Similar trends were observed when recording high-resolution images on top of individual cells (<xref ref-type="fig" rid="fig5">Figure 5E–H</xref>). While the surface of Δ<italic>CCNA_00163</italic> cell was smooth (surface roughness on 0.06 µm<sup>2</sup> areas of ∼0.9 nm) and featureless, Δ<italic>hvyA</italic> cells were rougher (roughness of ∼2.2 nm) and showed streaks in the scanning direction, suggesting that soft, loosely bound material was pushed away by the tip. In light of earlier AFM studies (<xref ref-type="bibr" rid="bib17">Dague et al., 2008</xref>), we note that such smooth and rough morphologies are consistent with the presence of crystalline-like arrays of proteins and of an amorphous layer of polysaccharides, respectively.<fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.03587.015</object-id><label>Figure 4.</label><caption><title>Negative fluorescence imaging of capsule.</title><p>(<bold>A</bold>) Differential Interference Contrast (DIC, top) and fluorescence images showing FITC-dextran exclusion (middle) or mCherry (bottom) of mixed Δ<italic>CCNA_00163</italic> (expressing mCherry) and Δ<italic>hvyA</italic> cells. The area of FITC-dextran exclusion of the non-capsulated Δ<italic>CCNA_00163</italic> cells is much smaller than that of the capsulated Δ<italic>hvyA</italic> cells. (<bold>B</bold>) Statistical analysis of the area from which FITC-dextran was excluded. The analysis was performed as described in the ‘Materials and methods’. (<bold>C</bold>) DIC (top) and fluorescence images showing FITC-dextran exclusion (middle) or mCherry (bottom) on NA1000 <italic>spmX-mCherry</italic> cells. SW and ST/PD cells were separated on density gradient before incubation with FITC-dextran. Area of exclusion of ST and PD cells (‘light’ cells, on the left) is much bigger than that of SW cells (on the right). SpmX-mCherry is absent from SW cells, accumulates at the SW to ST cell transition and labels the ST pole.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.015">http://dx.doi.org/10.7554/eLife.03587.015</ext-link></p></caption><graphic xlink:href="elife-03587-fig4-v1.tif"/></fig><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.03587.016</object-id><label>Figure 5.</label><caption><title>Nanoscale AFM imaging reveals the ultrastructure of <italic>Caulobacter</italic> cell surface.</title><p>Contact-mode deflection images of Δ<italic>CCNA_00163</italic> cells (<bold>A</bold>, <bold>C</bold>, <bold>E</bold>, <bold>G</bold>) and Δ<italic>hvyA</italic> cells (<bold>B</bold>, <bold>D</bold>, <bold>F</bold>, <bold>H</bold>) at low (<bold>A</bold>–<bold>D</bold>) and high (<bold>E</bold>–<bold>H</bold>) magnifications. White arrows indicate streaks generated by the AFM tip scanning the soft, loosely bound layer at the surface of Δ<italic>hvyA</italic> cells. Images were taken on bacteria from two independent cultures for each strain.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.016">http://dx.doi.org/10.7554/eLife.03587.016</ext-link></p></caption><graphic xlink:href="elife-03587-fig5-v1.tif"/></fig></p><p>Taken together our results show that Δ<italic>CCNA_00163</italic> cells are devoid of capsule, while a soft layer of capsular polysaccharides covers Δ<italic>hvyA</italic> cells. The results above raised the possibility that HvyA normally prevents capsulation in G1-phase cells, and FITC-dextran staining of an NA1000 culture expressing a ST cell marker (SpmX-mCherry) indeed revealed that G1-phase cells (i.e. SW cells isolated on density gradient) did not exclude the polymer and are thus non-capsulated, whereas ST/PD cells (‘light’ cells on density gradient) show a much bigger area of FITC-dextran exclusion (<xref ref-type="fig" rid="fig4">Figure 4C</xref>).</p></sec><sec id="s2-4"><title>HvyA abundance is restricted to G1-phase</title><p>The results above suggested that the G1-phase SW cells are able to synthesize capsule if HvyA is absent. To test if capsule export proteins are normally present in G1-phase cells, we raised antibodies to CCNA_00162, CCNA_00163, CCNA_00164, CCNA_00167, and CCNA_00168. Immunoblotting revealed that these components are present throughout the cell cycle of <italic>WT</italic> cells (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Owing to the poor specificity of the antibodies raised against HvyA, we engineered cells encoding a functional mCherry (mCh)-tagged HvyA derivative (mCh-HvyA) in which the mCherry moiety is fused in-frame after the SS. mCh-HvyA is expressed from the native <italic>hvyA</italic> promoter at the <italic>hvyA</italic> locus in lieu of untagged HvyA. Immunoblotting using polyclonal antibodies to mCherry revealed that mCh-HvyA is indeed restricted to G1-phase (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Antibiotic chase experiments showed that mCh-HvyA is a very unstable protein and is rapidly degraded akin to the unstable protein CtrA (<xref ref-type="fig" rid="fig6">Figure 6B</xref>), indicating that accumulation of HvyA is dictated by the timing of its synthesis (G1-phase).<fig-group><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.03587.017</object-id><label>Figure 6.</label><caption><title>HvyA is an unstable protein and its presence is restricted to G1-phase (SW cells).</title><p>(<bold>A</bold>) Immunoblots showing protein levels in synchronized <italic>Caulobacter</italic> cells: CCNA_00162, CCNA_00163, CCNA_00164, CCNA_00167, and CCNA_00168 levels do not change over the cell cycle. mCherry-HvyA accumulates only in SW cells, akin to CtrA. CcrM accumulates in PD cells, and PilA levels increase upon re-accumulation of CtrA. The β-lactamase (Bla) was used as control as it is constitutively present along the cell cycle. Molecular size standards are indicated in blue on the right, with the corresponding values in kDa. (<bold>B</bold>) Immunoblots showing degradation of mCherry-HvyA (indicated by the arrowhead) after addition of chloramphenicol (2 μg/ml) to stop protein synthesis. mCherry-HvyA is degraded as rapidly as the unstable protein CtrA (lower panel). Molecular size standards are indicated in blue on the right, with the corresponding values in kDa. (<bold>C</bold>) Immunoblot anti-mCherry-HvyA showing that levels of the mCherry-HvyA fusion protein (indicated by the arrowhead) are significantly decreased in the Δ<italic>mucR1</italic>/<italic>2</italic> mutant strain. Molecular size standards are indicated in blue on the right, with the corresponding values in kDa. Levels of CCNA_00162, CCNA_00163, CCNA_00164, CCNA_00167, and CCNA_00168 in <italic>Caulobacter</italic> cells over-expressing HvyA (from P<sub><italic>van</italic></sub>) are shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.017">http://dx.doi.org/10.7554/eLife.03587.017</ext-link></p></caption><graphic xlink:href="elife-03587-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.018</object-id><label>Figure 6—figure supplement 1.</label><caption><title>Over-expression of <italic>hvyA</italic> does not alter the levels of capsule polymerization/export components.</title><p>Immunoblots showing that the abundance and migration of capsule polymerization/export components is not affected by over-expression of <italic>hvyA</italic>. CCNA_00162, CCNA_00168, CCNA_00163, CCNA_00167 and CCNA_00164 are equally present in <italic>WT</italic> cells harbouring the empty vector (pMT335) or P<sub><italic>van</italic></sub>-<italic>hvyA</italic> (pMT335-<italic>hvyA</italic>). Molecular size standards are indicated in blue on the right, with the corresponding values in kDa. CCNA_00167 and CCNA_00164 are indicated by the arrowhead on the left of the corresponding panels.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.018">http://dx.doi.org/10.7554/eLife.03587.018</ext-link></p></caption><graphic xlink:href="elife-03587-fig6-figsupp1-v1.tif"/></fig></fig-group></p><p>Next, we explored if the G1-specific regulation of HvyA is due to transcriptional regulation by PleC. Using a <italic>lacZ</italic>-based promoter-probe reporter in which the <italic>hvyA</italic> promoter is transcriptionally fused to the <italic>lacZ</italic> gene (P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic>), we found that P<sub><italic>hvyA</italic></sub> is indeed positively dependent on PleC (41.1 ± 6.0% of <italic>WT</italic> activity, <xref ref-type="fig" rid="fig7">Figure 7A</xref>). Inactivation of the gene encoding the antagonistic DivJ kinase in Δ<italic>pleC</italic> cells mitigated this response (94.0 ± 19.9% of <italic>WT</italic> activity, <xref ref-type="fig" rid="fig7">Figure 7A</xref>). Consistent with the fact that PleC and DivJ regulate CtrA∼P levels, our recent chromatin immunoprecipitation coupled to deep-sequencing (ChIP-Seq) analyses indicated that CtrA indeed binds the <italic>hvyA</italic> promoter (P<sub><italic>hvyA</italic></sub>) and that this binding is strongly diminished in Δ<italic>pleC</italic> cells (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). Moreover, P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> is poorly active in <italic>ctrA401</italic> mutant cells (43.3 ± 1.9% of <italic>WT</italic> activity, <xref ref-type="fig" rid="fig7">Figure 7A</xref>) that express a temperature-sensitive version of CtrA (T170I) in lieu of <italic>WT</italic> CtrA (<xref ref-type="bibr" rid="bib50">Quon et al., 1996</xref>). By contrast, P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> is strongly de-repressed (574 ± 30% of <italic>WT</italic> activity, <xref ref-type="fig" rid="fig7">Figure 7A</xref>) in the absence of the paralogous repressors MucR1 and MucR2 (Δ<italic>mucR1/2)</italic> that directly bind P<sub><italic>hvyA</italic></sub> (<xref ref-type="fig" rid="fig7">Figure 7A</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>) and that silence many promoters of G1-phase genes (i.e. those that are activated by CtrA∼P after compartmentalization (<xref ref-type="bibr" rid="bib25">Fumeaux et al., 2014</xref>)). Thus, CtrA∼P and MucR1/2 directly activate and repress P<sub><italic>hvyA</italic></sub>, respectively (see <xref ref-type="fig" rid="fig8">Figure 8</xref>). Consistent with the latter, MucR1/2 also represses P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> activity in Δ<italic>pleC</italic> cells over-expressing <italic>WT</italic> or a phosphomimetic variant (D51E) of CtrA (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). Thus, <italic>hvyA</italic> (and other genes whose transcripts peak in G1, such as <italic>pilA</italic> and <italic>sciP</italic>) is expressed from a promoter that is temporally confined during the cell cycle via activation and repression by PleC/CtrA∼P and MucR1/2, respectively.<fig-group><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.03587.019</object-id><label>Figure 7.</label><caption><title>Transcriptional and translational regulation of <italic>hvyA</italic> depends on PleC-CtrA, SciP, and MucR1/2.</title><p>(<bold>A</bold>) Beta-galactosidase activity of P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> transcriptional fusion. Left panel: transcription of <italic>hvyA</italic> is strongly reduced in <italic>ctrA401</italic> (T170I, temperature sensitive) and Δ<italic>pleC</italic> strains compared to <italic>WT Caulobacter</italic>. Mutation of the kinase DivJ partially restores <italic>hvyA</italic> transcription in the Δ<italic>pleC</italic> Δ<italic>divJ</italic> strain. Transcription from P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> is significantly increased in the Δ<italic>mucR1</italic>/<italic>2</italic> mutant. Right panel: beta-galactosidase activity of P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> in Δ<italic>mucR1/2</italic> cells complemented with <italic>Caulobacter mucR1</italic> (<italic>CC_R1</italic>, <italic>WT</italic> or mutant derivatives Y97C and R85C) or the MucR paralogs from <italic>S. fredii</italic> NGR234 (<italic>Sf_a00320</italic> and <italic>Sf_c07580</italic>) on plasmid under control of P<sub><italic>van</italic></sub>. Values are expressed as percentages (activity in <italic>WT</italic> NA1000 or <italic>WT</italic> carrying the empty vector set at 100%). (<bold>B</bold>) Beta-galactosidase activity of P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> translational fusion in the same strains shown in panel (<bold>A</bold>). Translation of <italic>hvyA</italic> is strongly reduced in cells expressing the <italic>ctrA401</italic> allele and in the Δ<italic>pleC</italic> strain compared to <italic>WT Caulobacter</italic>. Mutation of DivJ partially restores <italic>hvyA</italic> translation in the Δ<italic>pleC</italic> Δ<italic>divJ</italic> strain. P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> activity is also significantly decreased in the Δ<italic>mucR1/2</italic> and Δ<italic>pleC</italic> Δ<italic>mucR1/2</italic> mutants, consistently with the ‘light’ buoyancy of these strains. P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> activity is restored in the Δ<italic>mucR1/2</italic> double mutant carrying <italic>ctrA(</italic>T170A<italic>)</italic>, <italic>sciP</italic>(T24I<italic>)</italic>, or <italic>sciP(</italic>T65A<italic>)</italic> alleles (<italic>ctrA*</italic> and <italic>sciP*</italic>). Values are expressed as percentages (activity in <italic>WT</italic> NA1000 or <italic>WT</italic> carrying the empty vector set at 100%). (<bold>C</bold>) Translational control of <italic>hvyA</italic> by CtrA and SciP. Beta-galactosidase activity of the P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> fusion in <italic>WT Caulobacter</italic> cells over-expressing <italic>sciP(</italic>T65A<italic>)</italic> or <italic>sciP(WT)</italic> from P<sub><italic>van</italic></sub> on plasmid. Whereas <italic>sciP(</italic>T65A<italic>)</italic> does not affect the activity of the translational P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> fusion, over-expression of <italic>sciP(WT)</italic> significantly decreases the activity of the fusion, consistently with the model presented in <xref ref-type="fig" rid="fig8">Figure 8</xref>. The activity is expressed as percentage of the activity in <italic>WT</italic> cells carrying the empty vector. Occupancy of CtrA, MucR1, and MucR2 at the <italic>hvyA</italic> promoter region as determined by ChIP-seq analysis is shown in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>. The effect of the CtrA(D51E) allele on P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> is shown in <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>. The ability of heterologous MucR to restore P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> repression or P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> activity in <italic>Caulobacter</italic> Δ<italic>mucR1/2</italic> is reported in <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3</xref>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.019">http://dx.doi.org/10.7554/eLife.03587.019</ext-link></p></caption><graphic xlink:href="elife-03587-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.020</object-id><label>Figure 7—figure supplement 1.</label><caption><title>Occupancy at the <italic>hvyA</italic> promoter region as determined by ChIP-seq analysis.</title><p>(<bold>A</bold>) Traces show occupancy of MucR1 (in blue), MucR2 (in purple), CtrA in <italic>WT</italic> cells (in green), and CtrA in Δ<italic>pleC</italic> cells (in red). In the absence of PleC, the occupancy of the <italic>hvyA</italic> promoter by CtrA is significantly reduced. (<bold>B</bold>) Same as panel <bold>A</bold>, but at a higher magnification to show the CtrA and MucR2 peaks that are otherwise masked by the MucR1 peak.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.020">http://dx.doi.org/10.7554/eLife.03587.020</ext-link></p></caption><graphic xlink:href="elife-03587-fig7-figsupp1-v1.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.021</object-id><label>Figure 7—figure supplement 2.</label><caption><title>Transcriptional control of <italic>hvyA</italic> by PleC-CtrA.</title><p>Beta-galactosidase activity of the P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> transcriptional fusion in <italic>WT</italic> and Δ<italic>pleC</italic> cells harbouring <italic>ctrA(WT)</italic> or the phosphomimetic <italic>ctrA(</italic>D51E<italic>)</italic> allele under control of P<sub><italic>van</italic></sub> on plasmid. The assay shows that the phosphomimetic <italic>ctrA(</italic>D51E<italic>)</italic> allele is unable to restore <italic>hvyA</italic> transcription in Δ<italic>pleC</italic> cells. The activity is expressed as percentage of the activity in <italic>WT</italic> cells carrying the empty vector.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.021">http://dx.doi.org/10.7554/eLife.03587.021</ext-link></p></caption><graphic xlink:href="elife-03587-fig7-figsupp2-v1.tif"/></fig><fig id="fig7s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.022</object-id><label>Figure 7—figure supplement 3.</label><caption><title>Transcriptional and translational control of <italic>hvyA</italic> by heterologous MucRs.</title><p>Beta-galactosidase activity of the P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> (transcriptional) and P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> (translational) fusions in Δ<italic>mucR1/2</italic> cells harbouring heterologous <italic>mucR</italic> genes under control of P<sub><italic>van</italic></sub> on plasmid. <italic>Cc_R1</italic>, <italic>Caulobacter mucR1</italic> (<italic>WT</italic> or mutant alleles); <italic>Cc_R1</italic> long, original annotation of <italic>Cc_R1</italic> (<italic>CCNA_00982</italic>); <italic>Sf_a00320</italic>, <italic>S. fredii NGR_a00320</italic>; <italic>Sf_c07580</italic>, <italic>S. fredii NGR_c07580</italic>; <italic>At_ROS</italic>, <italic>A. tumefaciens mucR</italic> paralog; <italic>Bs_mucR</italic>, <italic>B. suis mucR</italic> paralog; <italic>Bh_mucR</italic>, <italic>B. henseleae mucR</italic> paralog. The assay shows that in the presence of a heterologous MucR increased translational activity of P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> is always accompanied with a commensurate repression of the transcriptional P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic>. The activity is expressed as percentage of the activity in <italic>WT</italic> cells carrying the empty vector.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.022">http://dx.doi.org/10.7554/eLife.03587.022</ext-link></p></caption><graphic xlink:href="elife-03587-fig7-figsupp3-v1.tif"/></fig></fig-group><fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.03587.023</object-id><label>Figure 8.</label><caption><title>Model for regulation of HvyA synthesis and control of cell buoyancy/capsulation in <italic>Caulobacter</italic>.</title><p>In WT cells, <italic>hvyA</italic> transcription is activated by CtrA and repressed by MucR1/2, whereas translation is promoted by a (still unknown) factor (X, itself under control of CtrA and SciP like many late S phase genes). This tight regulation restricts HvyA synthesis to G1-phase, where HvyA prevents the encapsulation of the SW cell. In a Δ<italic>mucR1/2</italic> mutant, SciP is over-produced, which lowers the levels of the translational regulator of <italic>hvyA</italic> and prevents HvyA protein accumulation, despite de-repression of <italic>hvyA</italic> transcription. The presence of the <italic>ctrA(</italic>T170A<italic>)</italic>, <italic>sciP(</italic>T24I<italic>)</italic>, or <italic>sciP(</italic>T65A<italic>)</italic> alleles (<italic>ctrA</italic>* or <italic>sciP</italic>*) restores the synthesis of the factor X in the Δ<italic>mucR1/2</italic> mutant background, and therefore restores HvyA synthesis and WT buoyancy.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.023">http://dx.doi.org/10.7554/eLife.03587.023</ext-link></p></caption><graphic xlink:href="elife-03587-fig8-v1.tif"/></fig></p><p>Remarkably, regulation of P<sub><italic>hvyA</italic></sub> by MucR is conserved in <italic>S. meliloti</italic>. We found that P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> was strongly de-repressed (1683 ± 130% of <italic>WT</italic> activity) in a <italic>mucR</italic>::Tn mutant derivative (Rm101) of the <italic>S. meliloti WT</italic> strain (Rm2011, <xref ref-type="fig" rid="fig9">Figure 9A</xref>). Conversely, promoter probe assays in <italic>WT</italic> and <italic>mucR</italic> mutant cells of <italic>Caulobacter</italic> and <italic>S. meliloti</italic> revealed that the promoter of <italic>SMc00998,</italic> the <italic>S. meliloti hvyA</italic> ortholog that can partially substitute for <italic>C. crescentus hvyA</italic> (see below), is regulated by MucR in both these alpha-proteobacteria. The promoter probe plasmid P<sub><italic>SMc00998</italic></sub>-<italic>lacZ</italic> indicated that the <italic>SMc00998</italic> promoter is strongly de-repressed in <italic>S. meliloti mucR</italic>::Tn (314 ± 25% of <italic>WT</italic> activity) and the <italic>Caulobacter</italic> Δ<italic>mucR1/2</italic> mutant (568 ± 25% of <italic>WT</italic> activity, <xref ref-type="fig" rid="fig9">Figure 9B</xref>) compared to <italic>WT</italic>. Recent microarray data showed that the <italic>SMc00998</italic> transcript peaks in G1-phase and that its promoter harbours a CtrA-binding site (<xref ref-type="bibr" rid="bib18">De Nisco et al., 2014</xref>). Moreover, our ChIP-Seq analysis indicates that CtrA associates with the promoter of the <italic>hvyA</italic>-like gene <italic>NGR_c12490</italic> of <italic>Sinorhizobium fredii</italic> NGR234 (<xref ref-type="bibr" rid="bib25">Fumeaux et al., 2014</xref>). Thus, positive and negative transcriptional regulation by CtrA and MucR is potentially wide-spread in alpha-proteobacteria.<fig id="fig9" position="float"><object-id pub-id-type="doi">10.7554/eLife.03587.024</object-id><label>Figure 9.</label><caption><title>Conservation of <italic>hvyA</italic> transcriptional control and BTLCP function in alpha-proteobacteria.</title><p>(<bold>A</bold>) Beta-galactosidase activity of the P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> transcriptional fusion in <italic>WT</italic> and Δ<italic>mucR1/2</italic> cells compared to <italic>S. meliloti WT</italic> (Rm2011) and <italic>mucR</italic> mutant (<italic>mucR</italic>::Tn, Rm101). The assay shows that the transcriptional repression of P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> by MucR is conserved in <italic>S. meliloti</italic>. The activity is expressed as the percentage of the activity in (<italic>Caulobacter</italic> or <italic>S. meliloti</italic>) <italic>WT</italic> cells. (<bold>B</bold>) Beta-galactosidase activity of the P<sub><italic>SMc00998</italic></sub>-<italic>lacZ</italic> transcriptional fusion in <italic>WT</italic> and Δ<italic>mucR1/2</italic> cells compared to <italic>S. meliloti WT</italic> (Rm2011) and <italic>mucR</italic> mutant (<italic>mucR</italic>::Tn, Rm101). The assay shows that the HvyA paralog SMc00998 is also under transcriptional repression by MucR in both <italic>S. meliloti</italic> and <italic>Caulobacter</italic>. The activity is expressed as the percentage of the activity in (<italic>Caulobacter</italic> or <italic>S. meliloti</italic>) <italic>WT</italic> cells. (<bold>C</bold>) Sensitivity to φCr30 and buoyancy of <italic>C. crescentus</italic> Δ<italic>hvyA</italic> cells harbouring HvyA paralogs under control of P<sub><italic>van</italic></sub> on plasmid. Over-expression of <italic>NGR_c12490</italic> or <italic>SMc00998</italic> restores sensitivity to φCr30 and (partially) cell buoyancy, whereas <italic>NGR_c19800</italic>, <italic>NGR_c36180</italic>, or the <italic>A. tumefaciens</italic> paralog (<italic>Atu0252</italic>) are unable to complement the Δ<italic>hvyA</italic> mutation.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.024">http://dx.doi.org/10.7554/eLife.03587.024</ext-link></p></caption><graphic xlink:href="elife-03587-fig9-v1.tif"/></fig></p></sec><sec id="s2-5"><title>Cell cycle control of HvyA synthesis at the level of translation</title><p>Buoyancy tests with Δ<italic>mucR1/2</italic> cells unearthed another mechanism of cell cycle-control of HvyA synthesis: translational regulation. We uncovered this mechanism upon our erroneous prediction that Δ<italic>mucR1/2</italic> cells should be ‘heavy’ (non-capsulated). This prediction was based on the strong de-repression of P<sub><italic>hvyA</italic></sub> in the absence of MucR1/2 observed above and our result that overexpression of HvyA renders <italic>Caulobacter</italic> cells ‘heavy’. To our surprise, we found that Δ<italic>mucR1/2</italic> cells are in fact ‘light’ (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>) and only express trace amounts of mCh-HvyA (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). In support of the notion that a deficiency in HvyA underlies the buoyancy defect of this strain, the activity of a P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> translational fusion is indeed reduced in Δ<italic>mucR1/2</italic> cells (19.5 ± 5.4% of <italic>WT</italic> activity, <xref ref-type="fig" rid="fig7">Figure 7B</xref>), despite the massive de-repression of P<sub><italic>hvyA</italic></sub>. Moreover, constitutive expression of HvyA (on plasmid, from P<sub><italic>van</italic></sub> or P<sub><italic>xyl</italic></sub>) induced the ‘heavy’ (non-capsulated) phenotype in Δ<italic>mucR1/2</italic> cells (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). Expression of <italic>WT</italic> MucR1 from pMT335 alleviated both the buoyancy defect and P<sub><italic>hvyA</italic></sub> de-repression of Δ<italic>mucR1/2</italic> cells, while analogous plasmids encoding the mutant MucR1 derivatives Y97C or R85C were unable to do so (<xref ref-type="fig" rid="fig7">Figure 7A</xref>, <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3</xref>), indicating that these defects are indeed due to aberrant expression of a MucR1/2-dependent target gene.</p><p>Remarkably, MucRs from alpha-proteobacterial lineages can control transcription and translation of <italic>hvyA</italic>. In fact MucR orthologs from <italic>Agrobacterium tumefaciens</italic>, <italic>Brucella suis</italic>, <italic>Bartonella henselae,</italic> or <italic>S. fredii</italic> NGR234 (NGR_a00320 or NGR_c07580) can partially complement the <italic>Caulobacter</italic> Δ<italic>mucR1/2</italic> mutant. Interestingly, in the presence of a heterologous MucR, increased translational activity of P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> was always accompanied with a commensurate repression of the P<sub><italic>hvyA</italic></sub>-<italic>lacZ</italic> transcriptional reporter (<xref ref-type="fig" rid="fig7">Figure 7A, B</xref>, <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3</xref>). Specifically, while <italic>S. fredii</italic> NGR_c07580 and <italic>A. tumefaciens</italic> ROS were functional in transcriptional and translational regulation of <italic>hvyA</italic>, <italic>B. henselae</italic> MucR was inactive. However, <italic>B. suis</italic> MucR and <italic>S. fredii</italic> NGR_a00320 displayed an intermediate level of activity (47.0 ± 3.0% and 38.2 ± 2.7% of <italic>WT</italic> activity for P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> and 302.0 ± 11.1% and 283.5 ± 20.6% of <italic>WT</italic> activity for P<sub><italic>hvyA</italic></sub>-<italic>lacZ,</italic> respectively; <xref ref-type="fig" rid="fig7">Figure 7A,B</xref>, <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3</xref>).</p><p>How might MucR regulate the translation of <italic>hvyA</italic>? The results above, along with our finding that MucR1/2 acts pleiotropically, prompted us to speculate that another target of MucR1/2 is responsible for translational regulation of <italic>hvyA</italic>. Our experiments showed that the translational regulator of <italic>hvyA</italic> (X in <xref ref-type="fig" rid="fig8">Figure 8</xref>) is an indirect target of MucR1/2 and is deeply integrated into the cell cycle circuitry. Indeed, we observed that mutations in the master regulator gene <italic>ctrA</italic> [<italic>ctrA(</italic>T170A<italic>)</italic>] or its antagonist gene <italic>sciP</italic> [<italic>sciP(</italic>T24I<italic>)</italic> or <italic>sciP(</italic>T65A<italic>)</italic>] (<xref ref-type="bibr" rid="bib25">Fumeaux et al., 2014</xref>) are epistatic to the Δ<italic>mucR1/2</italic> mutation, as they conferred near normal P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> translation and a normal cellular buoyancy (capsulation) pattern with ‘heavy’ and ‘light’ cells, while P<sub><italic>hvyA</italic></sub> was still de-repressed (<xref ref-type="fig" rid="fig7">Figure 7A,B</xref>). In support of this view, over-expression of <italic>WT</italic> SciP from pMT335 cripples P<sub><italic>hvyA</italic></sub>-<italic>hvyA::lacZ</italic> translation (33.9 ± 4.7% of <italic>WT</italic> activity), while over-expression of SciP(T65A) only has negligible effects (83.8 ± 9.9% of <italic>WT</italic> activity; <xref ref-type="fig" rid="fig7">Figure 7C</xref>).</p><p>Importantly, we identified mechanisms for both transcriptional and translational regulation of <italic>hvyA</italic> in <italic>Caulobacter</italic> cells and showed that these two functions can be genetically uncoupled. This regulatory complexity highlights the requirement of proper buoyancy and capsulation control during the cell cycle. Since SciP is the negative regulator of S-phase genes (activated by CtrA at the PD cell stage <underline>before</underline> compartmentalization), while MucR1/2 negatively regulate G1-specific genes (activated by CtrA <underline>after</underline> compartmentalization), the coordinated transcriptional and translational control of <italic>hvyA</italic> by CtrA, MucR1/2, and SciP suggests that cells prepare themselves for the impending capsule-less SW cell phase by setting the stage for rapid translation of HvyA once the transcript is synthesized at compartmentalization.</p></sec><sec id="s2-6"><title>Capsule protects from infection by the S-layer-specific bacteriophage φCr30</title><p>As it has been suggested that the MGE and the buoyancy phenotype can influence the resistance profile to the S-layer specific Caulophage φCr30 (<xref ref-type="bibr" rid="bib22">Edwards and Smith, 1991</xref>; <xref ref-type="bibr" rid="bib2">Awarm and Smit, 1998</xref>), we evaluated this link and the possible involvement of <italic>hvyA</italic> quantitatively by genome-wide Tn mutagenesis followed by deep-sequencing (Tn-Seq) of <italic>Caulobacter</italic> cells challenged or not with bacteriophage φCr30. This analysis revealed that <italic>hvyA</italic> is one of the two major φCr30-resistance determinants, along with the <italic>rsaA</italic> locus encoding the RsaA subunit of the S-layer and CCNA_01057 that is predicted to function in S-layer assembly (<xref ref-type="bibr" rid="bib2">Awram and Smit, 1998</xref>) (<xref ref-type="fig" rid="fig10">Figure 10A</xref>). In fact, Tn insertions in <italic>hvyA</italic> and the <italic>rsaA</italic> gene are &gt;380 and &gt;160 times over-represented vs other genes in φCr30-challenged cells compared to those without phage, while insertions in <italic>CCNA_01057</italic> are over-represented &gt;400-fold upon phage treatment of cells, consistent with the S-layer serving as φCr30-receptor (<xref ref-type="bibr" rid="bib22">Edwards and Smit, 1991</xref>). As expected we observed that insertions in the PleC-regulated <italic>hvyA</italic> gene confer a growth advantage in the presence of φCr30, but we also found Tn insertions in <italic>pleC</italic> itself to be enriched (&gt;90-fold, <xref ref-type="fig" rid="fig10">Figure 10A</xref>). The reduction of Tn insertion bias in <italic>pleC</italic> compared to <italic>hvyA</italic> may be related to the residual expression of <italic>hvyA</italic> in <italic>pleC</italic> mutant cells (and thus lower fitness towards φCr30) compared to the complete absence of HvyA due to Tn insertions in <italic>hvyA</italic>.<fig-group><fig id="fig10" position="float"><object-id pub-id-type="doi">10.7554/eLife.03587.025</object-id><label>Figure 10.</label><caption><title>Inactivation of HvyA and ectopic presence of capsule protect cells from phage infection.</title><p>(<bold>A</bold>) Tn insertion bias in coding sequences (CDS) of NA1000 + φCr30 relative to <italic>WT</italic> cells as determined by Tn-seq. Peaks show CDSs with the highest number of Tn insertions. <italic>CCNA_01057</italic> is part of the S-layer locus and is required for S-layer assembly. CDSs with an insertion ratio higher than 50 are indicated (<italic>CCNA_00497</italic>, putative rhamnosyl transferase; <italic>CCNA_01199</italic>, putative glucose-1-P thymidylyltransferase; <italic>CCNA_03316</italic>, putative UDP-N-acetylglucosamine-4,6-dehydratase; <italic>CCNA_03744</italic>, putative dTDP-glucose-4,6-dehydratase). Non-coding sequences are not included. (<bold>B</bold>) Model showing how capsule can interfere with φCr30 infection. In <italic>WT</italic> NA1000, φCr30 can infect SW cells, whereas ST cells are protected by the capsule (in blue) that masks the S-layer (φCr30 receptor). In a Δ<italic>hvyA</italic> mutant, both cell types (SW and ST) are capsulated, which significantly reduces the ability of φCr30 to infect these cells. Conversely, in a capsule-less mutant (for example Δ<italic>hvyA CCNA_00163</italic>::Tn, like the mutants isolated in our buoyancy screen for ‘heavy’ cells), both cells types (SW and ST) can be infected by φCr30. Tn insertion bias in coding sequences (CDS) of NA1000 cells relative to NA1000 + φCr30 as determined by Tn-seq is shown in <xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1</xref>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.025">http://dx.doi.org/10.7554/eLife.03587.025</ext-link></p><p><supplementary-material id="SD1-data"><object-id pub-id-type="doi">10.7554/eLife.03587.026</object-id><label>Figure 10—source data 1.</label><caption><title>(xlsx) contains the insertion ratios obtained for the Tn-Seq experiment (column <bold>F</bold> was used to create <xref ref-type="fig" rid="fig10">Figure 10A</xref> and column G <xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1</xref>).</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.026">http://dx.doi.org/10.7554/eLife.03587.026</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-03587-fig10-data1-v1.xlsx"/></supplementary-material></p></caption><graphic xlink:href="elife-03587-fig10-v1.tif"/></fig><fig id="fig10s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.03587.027</object-id><label>Figure 10—figure supplement 1.</label><caption><title>Inactivation of capsule synthesis/export genes decreases <italic>Caulobacter</italic> fitness towards φCr30.</title><p>Tn insertion bias in coding sequences (CDS) of <italic>WT</italic> cells relative to NA1000 + φCr30 as determined by Tn-seq. Peaks indicate CDSs that received fewest insertions in NA1000 + φCr30 relative to untreated <italic>WT</italic> cells. The two loci that we identified as required for capsule biosynthesis/export are indicated (<italic>CCNA_00162</italic>-<italic>CCNA_00168</italic>, and <italic>CCNA_00460</italic>-<italic>CCNA_00481</italic>).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.027">http://dx.doi.org/10.7554/eLife.03587.027</ext-link></p></caption><graphic xlink:href="elife-03587-fig10-figsupp1-v1.tif"/></fig></fig-group></p><p>In contrast to the positive effects of the insertions in <italic>hvyA</italic> upon φCr30 challenge, Tn insertions in <italic>CCNA_00162-00168</italic> and <italic>CCNA_00460-00481</italic> were strongly under-represented (&gt;220- and &gt;120-fold, respectively) indicating that these genes have the opposite fitness effect, as would be predicted from our epistasis experiments on capsulation (<xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1</xref>). To confirm these Tn-Seq results, we conducted phage spot tests with serial dilutions of φCr30 on lawns of either <italic>WT</italic>, Δ<italic>hvyA,</italic> or Δ<italic>pleC</italic> cells and observed that deletion in <italic>hvyA</italic> or <italic>pleC</italic> did not yield cleared zones (cell lysis) where the phage had been spotted (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Complementation of the Δ<italic>hvyA</italic> strain with <italic>WT hvyA</italic> restored φCr30 sensitivity, whereas the catalytic point mutants (encoding C192S and H226Q) were unable to do so (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). In addition, Δ<italic>hvyA</italic> or Δ<italic>pleC</italic> strains harbouring Δ<italic>CCNA_00163 or</italic> Δ<italic>CCNA_00470</italic> mutations exhibited clearing zones (lysis) akin to the <italic>WT</italic> (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Thus, a Δ<italic>hvyA</italic> or Δ<italic>pleC</italic> mutation renders the entire population ‘light’, capsulated, and resistant to φCr30, while either a Δ<italic>CCNA_00163</italic> or Δ<italic>CCNA_00470 (</italic>akin to Δ<italic>CCNA_0162</italic>, Δ<italic>CCNA_00164</italic>, Δ<italic>CCNA_00167</italic>, <italic>CCNA_00168::Tn</italic> or Δ<italic>CCNA_03998</italic>; <xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="supplementary-material" rid="SD2-data">Supplementary file 1</xref>) mutation mitigates this effect, rendering the double mutants ‘heavy’, non-capsulated, and sensitive to φCr30. Moreover, the fact that mutations in <italic>pleC</italic>, <italic>hvyA,</italic> or <italic>CCNA_00163</italic> did not noticeably affect the release of the RsaA S-layer subunit from the cell surface (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref>) indicates that the S-layer is present and properly assembled in all the mutants.</p><p>On the basis of these results, we hypothesize that the capsule protects the S-layer from φCr30 (as depicted in the model in <xref ref-type="fig" rid="fig10">Figure 10B</xref>). Consistent with a protective role of the capsule for the cell surface and our results in spot tests with φCr30, we also observed higher frequencies of generalized transduction by φCr30 for non-capsulated strains compared to <italic>WT</italic>, Δ<italic>pleC,</italic> or Δ<italic>hvyA</italic> strains (<xref ref-type="table" rid="tbl2">Table 2</xref>). At the same time, treatment of intact cells with proteinase K showed that outer membrane proteins such as CCNA_00168 are more sensitive to the protease in Δ<italic>CCNA_00163</italic> mutant cells compared to <italic>WT</italic> or Δ<italic>hvyA</italic> strain (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>), which also supports a protective role of the capsule for the cell surface and illustrates its role in preventing φCr30 infection in <italic>Caulobacter</italic>.<table-wrap id="tbl2" position="float"><object-id pub-id-type="doi">10.7554/eLife.03587.028</object-id><label>Table 2.</label><caption><p>Transduction frequencies of φCr30 lysates in different <italic>Caulobacter</italic> strains</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.028">http://dx.doi.org/10.7554/eLife.03587.028</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center">Strain</th><th align="center"><italic>hvyA</italic>::pSA480</th><th align="center"><italic>CCNA_01524</italic>::Tn</th></tr></thead><tbody><tr><td align="center">NA1000 (<italic>WT</italic>)</td><td align="center">344</td><td align="center">∼750</td></tr><tr><td align="center">Δ<italic>pleC</italic></td><td align="center">64</td><td align="center">165</td></tr><tr><td align="center">Δ<italic>hvyA</italic></td><td align="center">48</td><td align="center">162</td></tr><tr><td align="center">Δ<italic>CCNA_00163</italic></td><td align="center">522</td><td align="center">≥1000</td></tr><tr><td align="center">Δ<italic>pleC</italic> Δ<italic>CCNA_00163</italic></td><td align="center">527</td><td align="center">≥1000</td></tr><tr><td align="center">Δ<italic>hvyA</italic> Δ<italic>CCNA_00163</italic></td><td align="center">487</td><td align="center">≥1000</td></tr></tbody></table><table-wrap-foot><fn><p>For transduction, cells were normalised according to the OD600 and infected with the same amount of φCr30; two different markers were transduced, a pGS18T derivative integrated at the <italic>hvyA</italic> locus (pSA480) and a <italic>himar1</italic> insertion in <italic>CCNA_01524</italic> (flagellar modification gene, unrelated to cellular buoyancy or capsule production). The number of colonies counted after 3 days of incubation at 30°C is reported. The experiment was repeated twice.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s2-7"><title>Conservation of HvyA function in other alpha-proteobacteria</title><p>The connection among capsulation, buoyancy, and φCr30 resistance phenotypes prompted us to probe these phenotypes in structure–function analyses with HvyA. To this end, we exploited the HvyA overexpression phenotype to seek HvyA mutant derivatives with impaired function. Briefly, a plasmid (pUG52) expressing a HvyA-derivative with a C-terminal TAP (<underline>t</underline>andem <underline>a</underline>ffinity <underline>p</underline>urification) tag (<xref ref-type="bibr" rid="bib49">Puig and et al., 2001</xref>) under the control of P<sub><italic>van</italic></sub> was subjected to random mutagenesis and subsequently introduced into the <italic>WT</italic> and the Δ<italic>hvyA</italic> mutant strain. Whereas this plasmid normally renders cells ‘heavy’ (non-capsulated) due to overexpression of HvyA-TAP, serial enrichment of the mutant pool by density gradient centrifugation led to recovery of ‘light’ mutants (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Following immunoblotting of candidate strains for those still overexpressing HvyA-TAP (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A</xref>), we recovered a number of mutants with single amino acid substitutions within the BTLCP domain of HvyA. Among these variants we recovered mutants in or very close to the putative catalytic site (H226Y, D194G, L240R), as well as mutations in conserved (W178S), similar (R161P) or non-conserved (P263R) residues throughout the BTLCP domain (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). While the isolation of the mutations in the catalytic centre validated the forward genetic screen, upon re-testing the mutants three of them (R161P, D194G, and P263R) exhibited complete loss-of-function with respect to buoyancy but only partial loss-of-function with respect to φCr30 sensitivity under conditions of maximal induction of the P<sub><italic>van</italic></sub> promoter on the plasmid. In fact, these mutants were able to support replication of φCr30 (as shown by cells lysis in <xref ref-type="fig" rid="fig3">Figure 3G</xref>), indicating that they are indeed partially functional and that the φCr30 spot assay is much more sensitive as readout, possibly because localized breaches in the capsule are sufficient to promote φCr30 infection at a high multiplicity of infection (m.o.i.). By contrast, the other missense mutants from the screen (W178S, H226Y, and L240R) neither restored φCr30-sensitivity nor buoyancy (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). To confirm that mutations in the BTLCP do not affect sorting to the periplasm, we released periplasmic components by treating cells with EGTA (<underline>e</underline>thylene-<underline>g</underline>lycol-<underline>t</underline>etraacetic <underline>a</underline>cid), which is known to destabilize the outer membrane (<xref ref-type="bibr" rid="bib54">Raetz et al., 2007</xref>). Such treatment effectively liberated the beta-lactamase encoded by <italic>Caulobacter</italic> (CCNA_02223) along with WT or mutant HvyA-TAP variants, but not cytoplasmic proteins such as CtrA (<xref ref-type="fig" rid="fig3">Figure 3C,F</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref>).</p><p>Prompted by the identification of the functional site in the <italic>Caulobacter</italic> BTLCP, we asked if heterologous BTLCPs support HvyA function in <italic>Caulobacter</italic>. While this was not the case for the BTLCP from <italic>A. tumefaciens</italic> (Atu0252) or two HvyA paralogs from <italic>S. fredii</italic> NGR234 (NGR_c19800 and NGR_c36180), the BTLCP homologs SMc00998 and NGR_c12490 from <italic>S. meliloti</italic> and <italic>S. fredii</italic> NGR234, respectively, restored φCr30-sensitivity and partially compensated for the buoyancy defect of Δ<italic>hvyA</italic> cells (<xref ref-type="fig" rid="fig9">Figure 9C</xref>). Thus, despite adaptation to dissimilar ecological niches during evolution, alpha-proteobacterial lineages have retained and exhibit related BTLCP activity.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The intricate transcriptional and translational regulatory circuit acting on the unstable BTLCP homolog HvyA confines its presence, and thus activity, to a specific phase (G1) in the <italic>Caulobacter</italic> cell cycle. An inhibitor of encapsulation, HvyA ensures that G1 cells are capsule-less and that upon its elimination during the G1→S transition encapsulation can commence. In light of this first demonstration of cell cycle-regulated capsulation and the importance of capsule in masking, preventing, or impeding immune responses in bacterial pathogens, our results raise the intriguing possibility of targeting specifically the G1-phase regulatory hierarchy to combat bacterial infections by crippling encapsulation mechanisms. This can be achieved either by inhibiting capsular functions such as export or biosynthesis or, alternatively, by potentiating or sustaining the action of capsule inhibitors, such as <italic>Caulobacter</italic> HvyA, throughout the cell cycle. Our genetic dissection of the regulatory complexity underlying HvyA synthesis, involving cell cycle-controlled transcription and translation, provides a possible entry point for achieving such dysregulation to prevent capsulation. Noteworthy are our results showing that the mechanisms directing <italic>hvyA</italic> transcription in G1-phase are also operational in other alpha-proteobacteria. Interference with HvyA proteolysis at the G1→S transition presents another strategy to obtain capsule-less cells. However, possible strategies in doing so await the identification of the periplasmic protease responsible for the proteolytic degradation of HvyA.</p><p>In addition to offering protection from immune cells, capsulation is a known resistance mechanism to bacteriophage adsorption (<xref ref-type="bibr" rid="bib32">Hyman and Abedon, 2010</xref>). Our data show that in <italic>Caulobacter</italic> the T4-like phage φCr30 is obstructed by capsulation. As the G1-specific inhibition of capsulation by HvyA is released with the removal of HvyA during the G1→S transition, the nascent S-phase cells are protected from infection by φCr30. As φCr30 is a generalized transducing bacteriophage, this temporal confinement of capsulation also has the consequence of limiting φCr30-mediated horizontal exchange of genetic material to SW cells.</p><p>Temporal control of capsulation may also serve to prevent steric interference on the flagellar rotation by the capsule in the motile G1-phase. Steric hindrance of flagellar function by extracellular polysaccharides is well documented in other bacteria (<xref ref-type="bibr" rid="bib6">Blair et al., 2008</xref>; <xref ref-type="bibr" rid="bib34">Jarrell and McBride, 2008</xref>) and, consistent with this notion, we observed a slight reduction in the motility of Δ<italic>hvyA</italic> cells compared to <italic>WT</italic> or the Δ<italic>hvyA</italic> Δ<italic>CCNA_00167</italic> double mutant (<xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5</xref>). In S-phase cells the capsule may confer protection from certain bacteriophages or other predators while also endowing S-phase cells with the buoyancy that maintains them near high oxygen tensions at the surface of aqueous environments. A strict aerobe, <italic>Caulobacter</italic>, and S-phase cells in particular may have demand for energy production by respiration.</p><p>BTLCPs are particularly widespread in alpha-proteobacterial genomes and are also found in certain gamma-proteobacterial clades such as <italic>Pseudomonads</italic> and <italic>Vibrios</italic>, but they appear to act on specific targets in these lineages. In <italic>Caulobacter</italic>, the HvyA coding sequence is embedded in the CPS export locus, but in other alpha-proteobacteria HvyA-like BTLCPs appear to be encoded in other genomic context(s), so they probably affect also phenotypes unrelated to surface polysaccharides, mucoidy, and/or buoyancy. However, BTLCPs are predicted to have signal sequences for export into the periplasm and are often encoded in the vicinity of trans-envelope transport systems or enzymes predicted to act in the periplasm, suggesting that they act on periplasmic or extra-cytoplasmic targets. Consistent with an enzymatic activity, mutations in predicted catalytic residues of HvyA abrogate function and we were able to demonstrate limited promiscuity among HvyA, NGR_c12490, and SMc00998 <italic>in vivo</italic>, at least under conditions of over-expression. Such protein crosstalk is not unexpected and has also been documented between non-cognate histidine kinases and response regulators for example. The crosstalk among the three transglutaminase/protease-like enzymes HvyA, NGR_c12490, and SMc00998 indicates similar targets in <italic>Caulobacter</italic> and <italic>Sinorhizobia</italic>. Unlike HvyA, NGR_c12490, and SMc00998, coding sequences are not embedded within genes encoding known surface polysaccharides export proteins. However, over-expression of HvyA did not alter the abundance or migration of the CPS export proteins CCNA_00162, CCNA_00163, CCNA_00164, CCNA_00167, and CCNA_00168 by SDS-PAGE immunoblotting, or the amount of assembled RsaA S-layer subunit (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), indicating that HvyA is not required to maintain the steady state levels of these proteins. The distant HvyA relative LapG from <italic>Pseudomonas fluorescens</italic> cleaves the cell surface adhesin LapA that is encoded nearby in <italic>P. fluorescens,</italic> but not found in <italic>Pseudomonas aeruginosa, Legionella pneumophila</italic>, or <italic>C. crescentus</italic> genomes (<xref ref-type="bibr" rid="bib46">Newell et al., 2009</xref>; <xref ref-type="bibr" rid="bib45">Navarro et al., 2011</xref>; <xref ref-type="bibr" rid="bib47">Newell et al., 2011</xref>; <xref ref-type="bibr" rid="bib11">Chatterjee et al., 2012</xref>). While the target of the LapG ortholog from <italic>L. pneumophila</italic> is unknown, this enzyme can cleave <italic>P. fluorescens</italic> LapA <italic>in vitro</italic> (<xref ref-type="bibr" rid="bib11">Chatterjee et al., 2012</xref>). LapG is regulated at the level of activity by sequestration to the cytoplasmic membrane by the cyclic-di-GMP responsive trans-membrane receptor LapD (<xref ref-type="bibr" rid="bib45">Navarro et al., 2011</xref>). Moreover, the Ca<sup>2+</sup> ions not only promote outer membrane integrity, but also stimulate the cleavage of LapA by LapG in <italic>P. fluorescens</italic> (<xref ref-type="bibr" rid="bib7">Boyd et al., 2012</xref>). Residues predicted to bind Ca<sup>2+</sup> ions are conserved in HvyA, and our unbiased structure–function analyses indeed unearthed mutations in conserved residues that are important for HvyA function. Thus, while control of HvyA activity by Ca<sup>2+</sup> ions could contribute to control of HvyA action on its proper targets within the envelope, the tight regulation of HvyA (and its orthologs) abundance during the alpha-proteobacterial cell cycle represents the major regulatory mechanism to constrain BTLCP activity temporally.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Strains and growth conditions</title><p><italic>Caulobacter crescentus</italic> NA1000 (<xref ref-type="bibr" rid="bib24">Evinger and Agabian, 1977</xref>) and derivatives were grown at 30°C in PYE (peptone-yeast extract) or M2G (minimal glucose). <italic>Sinorhizobium fredii</italic> NGR234 (<xref ref-type="bibr" rid="bib64">Stanley et al., 1988</xref>) was grown at 30°C in TY (tryptone-yeast extract). <italic>Sinorhizobium meliloti</italic> Rm2011 and derivatives (<xref ref-type="bibr" rid="bib9">Casse, 1979</xref>; <xref ref-type="bibr" rid="bib3">Becker et al., 1997</xref>) were grown at 30°C in Luria broth (LB) supplemented with CaCl<sub>2</sub> 2.5 mM and MgSO<sub>4</sub> 2.5 mM. <italic>Escherichia coli</italic> S17-1 <italic>λpir</italic> (<xref ref-type="bibr" rid="bib60">Simon et al., 1983</xref>), EC100D, EC100D <italic>pir-116</italic> (Epicentre Technologies, Madison, WI), and Rosetta(DE3)pLysS (Merck KGaA, Darmstadt, Germany) were grown at 37°C in LB. The <italic>E. coli</italic> mutator strain XL-1 Red (Agilent Technologies Inc., Cedar Creek, TX) was grown at 30°C in LB. Motility assays, swarmer cells isolation, electroporations, biparental matings, and bacteriophage φCr30-mediated generalized transductions were performed as described (<xref ref-type="bibr" rid="bib23">Ely, 1991</xref>; <xref ref-type="bibr" rid="bib71">Viollier and Shapiro, 2003</xref>; <xref ref-type="bibr" rid="bib72">Viollier et al., 2004</xref>; <xref ref-type="bibr" rid="bib12">Chen et al., 2005</xref>). Nalidixic acid, kanamycin, gentamicin, and tetracycline were used at 20 (8 for <italic>S. meliloti</italic>), 20, 1 (10 for <italic>E. coli</italic> and <italic>S. meliloti</italic>), and 1 (10 for <italic>E. coli</italic> and <italic>S. meliloti</italic>) μg/ml, respectively. Plasmids for β-galactosidase assays were introduced into <italic>S. meliloti</italic> by bi-parental mating and into <italic>C. crescentus</italic> by electroporation.</p></sec><sec id="s4-2"><title>Isolation of ‘heavy’ <italic>himar1</italic> (Tn) mutants</title><p>Transposon mutagenesis of Δ<italic>pleC</italic> and Δ<italic>hvyA</italic> strains was done by intergeneric conjugation from <italic>E. coli</italic> S17-1 <italic>λpir</italic> harbouring the <italic>himar1</italic>-derivative pHPV414 as previously described (<xref ref-type="bibr" rid="bib72">Viollier et al., 2004</xref>). All the nalidixic acid and kanamycin resistant clones were pooled and grown in liquid medium before isolation of ‘heavy’ cells by centrifugation on density gradient. The isolated ‘heavy’ cells were subjected to three subsequent steps (of growth in liquid medium and centrifugation on density gradient) in order to obtain enrichment in ‘heavy’ mutant cells. After the third step of selection, ‘heavy’ cells were plated to obtain single colonies, and single Tn insertion sites were mapped by partial digestion of genomic DNA with <italic>Hin</italic>PI, religation, transformation of rescued plasmids into <italic>E. coli</italic> EC100D-<italic>pir</italic>116 and identification of insertion sites by sequencing as previously described (<xref ref-type="bibr" rid="bib72">Viollier et al., 2004</xref>). The nucleotide positions of all mapped Tn insertions are reported in <xref ref-type="supplementary-material" rid="SD3-data">Supplementary file 2</xref>.</p></sec><sec id="s4-3"><title>Genome-wide transposon mutagenesis coupled to deep sequencing (Tn-Seq)</title><p>Transposon mutagenesis of <italic>C. crescentus</italic> NA1000 was done by intergeneric conjugation from <italic>E. coli</italic> S17-1 <italic>λpir</italic> harbouring the <italic>himar1</italic>-derivative pHPV414 (<xref ref-type="bibr" rid="bib72">Viollier et al., 2004</xref>). Pools of Tn mutants of &gt;100,000 kanamycin and nalidixic acid resistant clones were obtained for NA1000 grown either in the presence or absence of bacteriophage φCr30. To enrich the Tn pool for φCr30-resistant clones, after conjugation NA1000 cells were embedded into soft agar containing the appropriate antibiotics as well as φCr30 (at m.o.i. ≥2). After incubation of the plates at 30°C for 48 hr, all the clones were pooled for each Tn collection and chromosomal DNA was extracted. Sequencing (Illumina HiSeq 2000) and analysis were done as described previously (<xref ref-type="bibr" rid="bib44">Murray et al., 2013</xref>).</p></sec><sec id="s4-4"><title>Production of antibodies and immunoblots</title><p>For the production of antibodies, His<sub>6</sub>-SUMO-CCNA_00162<sub>(51-422)</sub>, CCNA_00163<sub>(101-300)</sub>-His<sub>6</sub>, His<sub>6</sub>-SUMO-CCNA_00164<sub>(481-620)</sub>, His<sub>6</sub>-HvyA<sub>(26-272)</sub>, His<sub>6</sub>-CCNA_00167<sub>(1-108)</sub>, His<sub>6</sub>-SUMO-CCNA_00168<sub>(41-198)</sub>, and CCNA_02223<sub>(22-289)</sub>-His<sub>6</sub> were expressed in <italic>E. coli</italic> Rosetta (DE3)pLysS cells and the recombinant proteins were purified using Ni-NTA agarose (Qiagen, Hilden, Germany). His<sub>6</sub>-SUMO-CCNA_00168<sub>(41-198)</sub> and CCNA_02223<sub>(22-289)</sub>-His<sub>6</sub> were purified in the soluble fraction and directly used to immunize rabbits (Josman LLC, Napa, CA). Purified His<sub>6</sub>-SUMO-CCNA_00162<sub>(51-422)</sub>, CCNA_00163<sub>(101-300)</sub>-His<sub>6</sub>, His<sub>6</sub>-SUMO-CCNA_00164<sub>(481-620)</sub>, His<sub>6</sub>-HvyA<sub>(26-272)</sub>, and His<sub>6</sub>-CCNA_00167<sub>(1-108)</sub> were excised from 12.5% SDS polyacrylamide gels and used to immunize rabbits. For immunoblots, protein samples were separated on SDS polyacrylamide gel, transferred to polyvinylidene difluoride (PVDF) Immobilon-P membranes (Merck Millipore), and blocked in PBS (phosphate saline buffer), 0.1% Tween20, and 5% dry milk. The anti-sera were used at the following dilutions: anti-CtrA (1:10,000) (<xref ref-type="bibr" rid="bib19">Domian et al., 1997</xref>), anti-PilA (1:10.000) (<xref ref-type="bibr" rid="bib73">Viollier et al., 2002</xref>), anti-CcrM (1:10,000) (<xref ref-type="bibr" rid="bib65">Stephens et al., 1996</xref>), anti-mCherry (1:10,000) (<xref ref-type="bibr" rid="bib12">Chen et al., 2005</xref>), anti-CCNA_00162 (1:20,000), anti-CCNA_00163 (1:100,000), anti-CCNA_00164 (1:10,000), anti-HvyA (1:10,000), anti-CCNA_00167 (1:10,000), anti-CCNA_00168 (1:20,000), anti-β-lactamase (anti-Bla, 1:20,000). Protein-primary antibody complexes were visualized using horseradish peroxidase-labelled anti-rabbit antibodies and ECL detection reagents (Merck Millipore).</p></sec><sec id="s4-5"><title>Release of periplasmic proteins by EGTA</title><p>Cultures (8 ml) were grown to exponential phase (OD<sub>600nm</sub> ∼ 0.6), centrifuged and washed twice with HEPES 10 mM pH 7.2. Cells were re-suspended in HEPES 10 mM pH 7.5 containing 10 mM EGTA (ethylene glycol tetraacetic acid) and incubated at room temperature for 10 min. Cells were then pelleted by centrifugation and 20 μl of supernatant loaded on a 7.5% SDS polyacrylamide gel, followed by Coomassie Blue staining.</p></sec><sec id="s4-6"><title>HvyA stability analysis</title><p><italic>C. crescentus</italic> cells expressing mCh-HvyA from the <italic>hvyA</italic> locus on the chromosome were grown in PYE to exponential phase (OD<sub>600nm</sub> ∼ 0.6) before adding chloramphenicol (2 μg/ml). CtrA or mCh-HvyA levels were monitored by immunoblotting of samples taken at different time points after addition of chloramphenicol.</p></sec><sec id="s4-7"><title>Proteolysis of surface proteins</title><p><italic>C. crescentus</italic> cells (<italic>WT</italic>, Δ<italic>hvyA</italic>, or Δ<italic>CCNA_00163</italic>) were grown in PYE to exponential phase (OD<sub>600nm</sub> ∼ 0.6), pelleted by centrifugation, and re-suspended in 20 mM Tris, pH 7.5, 100 mM NaCl. The susceptibility of surface proteins to proteolysis was determined by treating whole cells with 0.5 mg/ml proteinase K; after incubation at 37°C (15, 30, 45, or 60 min), 1× protease inhibitors (Complete EDTA-free, Roche, Switzerland) were added. The cells were washed four times with 20 mM Tris (pH 7.5), 100 mM NaCl, 1× protease inhibitors, re-suspended in SDS-PAGE loading buffer and boiled. Protein samples were analysed by immunoblotting using antibodies to CCNA_00168.</p></sec><sec id="s4-8"><title>Site-directed mutagenesis of <italic>hvyA</italic></title><p>In order to create <italic>hvyA</italic> alleles mutated in the predicted catalytic residues, the <italic>hvyA</italic> ORF was sub-cloned into pOK12 (<xref ref-type="bibr" rid="bib70">Vieira and Messing, 1991</xref>) as <italic>Nde</italic>I/<italic>Eco</italic>RI fragment from pMT335-<italic>hvyA</italic>. pOK-<italic>hvyA</italic> was used as a template for oligonucleotide site-directed mutagenesis. Two complementary oligonucleotide primers containing the desired mutation were designed for each point mutation (<xref ref-type="supplementary-material" rid="SD6-data">Supplementary file 5</xref>). PCR reactions were composed of 30 cycles, carried out under the following conditions: denaturation, 94°C for 1 min; annealing, 60°C for 1 min; extension, 68°C for 8 min. The PCR products were treated with <italic>Dpn</italic>I to digest the template DNA and used to transform <italic>E. coli</italic> EC100D competent cells. The constructions obtained were verified by sequencing and sub-cloned as <italic>Nde</italic>I/<italic>Eco</italic>RI fragments into pMT335. In order to create TAP-tagged versions of the point mutants, the <italic>hvyA</italic> mutant alleles were amplified from pOK12 with hvyA_N and hvyA_CTIF primers and cloned into a pMT335 derivative harbouring the TAP epitope cloned as <italic>EcoR</italic>I/<italic>Xba</italic>I fragment (<xref ref-type="bibr" rid="bib53">Radhakrishnan et al., 2010</xref>).</p></sec><sec id="s4-9"><title>Isolation of HvyA non-functional alleles</title><p>The HvyA loss-of-function alleles (R161P, W178S, D194G, H226Y, L240R, and P263R) were obtained following random mutagenesis of pUG52, which was passed through the <italic>E. coli</italic> mutator strain XL1-Red. The mutant pUG52 library was electroporated into <italic>WT</italic> NA1000 or the Δ<italic>hvyA</italic> strain. The transformants were pooled and subjected to centrifugation on density gradient, in order to isolate ‘light’ cells. These ‘light’ cells were grown in liquid medium and then subjected to three subsequent rounds of isolation by centrifugation on density gradient to obtain enrichment in ‘light’ cells. Cells isolated in the last density gradient were plated to obtain single colonies, from which we recovered the plasmid. Nine plasmids were sequenced and we identified six different mutations: clones L006 and L011 encoded the W178S variant, L009 encoded D194G, L101 encoded P263R, L102 and L110 encoded L240R, L104 and L111 encoded R161P, and L105 encoded H226Y.</p></sec><sec id="s4-10"><title>β-galactosidase assays</title><p>β-galactosidase assays were performed at 30°C. Cells (50–200 μl) at OD<sub>660nm</sub> = 0.1–0.5 were lysed with chloroform and mixed with Z buffer (60 mM Na<sub>2</sub>HPO<sub>4</sub>, 40 mM NaH<sub>2</sub>PO<sub>4</sub>, 10 mM KCl, and 1 mM MgSO<sub>4</sub>, pH 7) to a final volume of 800 μl. 200 μl of ONPG (o-nitrophenyl-β-D-galactopyranoside, stock solution 4 mg/ml in 0.1 M potassium phosphate, pH 7) were added and the reaction timed. When a medium-yellow colour developed, the reaction was stopped by adding 400 μl of 1M Na<sub>2</sub>CO<sub>3</sub>. The OD<sub>420nm</sub> of the supernatant was determined and the Miller units (U) were calculated as follows: U = (OD<sub>420nm</sub> * 1000)/(OD<sub>660nm</sub> * time [in min] * volume of culture used [in ml]). Error was computed as standard deviation (SD).</p></sec><sec id="s4-11"><title>Capsule glycosyl composition analysis</title><p><italic>C. crescentus</italic> cells grown in 2L PYE were pelleted by centrifugation, washed twice with phosphate saline buffer (PBS, pH 7.5), and lyophilized. Lyophilized cells were used for the purification of capsular polysaccharides, which was performed using a modification of the method described by <xref ref-type="bibr" rid="bib55">Ravenscroft et al. (1991)</xref> followed by glycosyl compositional analysis conducted by combined gas chromatography/mass spectrometry (GC/MS) of the per-<italic>O</italic>-trimethylsilyl (TMS) derivatives of the monosaccharide methyl glycosides produced by acidic methanolysis. Briefly, after treatment of cellular lysates with 95% ethanol for polysaccharide enrichment, contaminants such as DNA, RNA, and proteins were removed by successive digestion with DNase I, RNase A, and proteinase K. Every enzymatic digestion step was followed by dialysis against distilled deionized water. Samples were then subjected to ultracentrifugation (100,000×<italic>g</italic>, 18 hr, 4°C) to pellet lipopolysaccharide (LPS). The supernatant containing capsular polysaccharides was freeze-dried and used for glycosyl composition analysis. Inositol (20 μg) was added, as internal standard, to 500 μg of each sample. Polysaccharides were first hydrolysed with 2 M trifluoroacetic acid (TFA) at 120°C for 2 hr. Methyl glycosides were prepared from the dry samples by mild acid treatment (methanolysis in 1 M HCl in methanol at 80°C for 16 hr) followed by re-acetylation with pyridine and acetic anhydride in methanol (for detection of amino-sugars). The samples were then per-<italic>O</italic>-trimethylsilylated by treatment with Tri-Sil reagent (Thermo Scientific Pierce, Rockford, IL) at 80°C for 30 min (<xref ref-type="bibr" rid="bib78">York et al., 1985</xref>; <xref ref-type="bibr" rid="bib43">Merkle and Poppe, 1994</xref>). Gas chromatography/mass spectrometry (GC/MS) analysis of the TMS methyl glycosides was performed on an Agilent 7890A GC interfaced to a 5975C MSD, using an Agilent DB-1 fused silica capillary column (30 mm × 0.25 mm ID).</p></sec><sec id="s4-12"><title>Microscopy and fluorescence isothiocyanate (FITC)-dextran exclusion assay</title><p>Fluorescence and DIC imaging of <italic>Caulobacter</italic> cells were conducted as previously described (<xref ref-type="bibr" rid="bib52">Radhakrishnan et al., 2008</xref>).</p><p>FITC-dextran with average mass of 2000 kDa (Sigma-Aldrich, St. Louis, MO) was used to assess capsule thickness as previously described (<xref ref-type="bibr" rid="bib26">Gates et al., 2004</xref>). Briefly, cells were grown in PYE supplemented with 1% sucrose to a final OD<sub>600nm</sub> = 1.2. 500 μl of each culture were mixed, harvested by centrifugation at room temperature (3000×<italic>g</italic>, 5 min), washed once with PBS, and resuspended in 30 μl of PBS. 10 μl of bacterial suspension was mixed with 2 μl of FITC-dextran (10 mg/ml in water), applied onto a microscope slide, and firmly covered with a coverslip. Cells expressing SpmX-mCherry were grown in PYE supplemented with 1% sucrose to a final OD<sub>600nm</sub> = 0.6. SW and ST/PD cells were separated by centrifugation on density gradient, then washed with PBS, and incubated with FITC-dextran as described above. The samples were imaged as described for fluorescence and DIC images (<xref ref-type="bibr" rid="bib52">Radhakrishnan et al., 2008</xref>). Images were analyzed with the MATLAB-based open-source software MicrobeTracker (<xref ref-type="bibr" rid="bib63">Sliusarenko et al., 2011</xref>). Statistics were calculated using Graphpad Prism 4 and statistical significance was determined using a two-tailed Mann–Whitney test.</p></sec><sec id="s4-13"><title>AFM imaging of <italic>Caulobacter</italic> cells</title><p><italic>Caulobacter</italic> cells grown overnight in liquid PYE were rinsed in PBS buffer and resuspended in 4% paraformaldehyde (Sigma-Aldrich) solution for 1 hr at room temperature for fixation. Cells were then rinsed in PBS buffer and filtered through polycarbonate porous membrane (Millipore, Billerica, MA, pore size: 3 µm). AFM imaging was performed using a Nanoscope VIII Multimode (Bruker Corporation, Santa Barbara, CA) and oxide-sharpened microfabricated Si<sub>3</sub>N<sub>4</sub> cantilevers with a nominal spring constant of ∼0.01 N/m (Microlevers, Veeco Metrology Group). After filtering the cell culture, the filter was gently rinsed with the buffer, carefully cut (1 cm × 1 cm), attached to a steel sample puck using a small piece of double face adhesive tape, and the mounted sample was transferred into the AFM liquid cell while avoiding dewetting. Images were taken in PBS buffer in contact mode under minimal applied force. Images were analysed using Nanoscope 8.10 software (Bruker, Santa Barbara, CA). Rms (root mean square) roughness values were calculated on 250 × 250 nm<sup>2</sup> areas of the high magnification height images subjected to second order filtering.</p></sec><sec id="s4-14"><title>Plasmid and strain construction</title><p>In-frame deletions and replacement of <italic>hvyA</italic> by a <italic>mCherry-hvyA</italic> N-terminal fusion (strain SA1737) were created using pNPTS138 derivatives constructed as follows:<list list-type="simple"><list-item><p>pNPTS<italic>_</italic>Δ<italic>00162</italic>: PCR was used to amplify two DNA fragments flanking the <italic>CCNA_00162</italic> ORF, by using primers 162_ko1/162_ko2 and 162_ko3/162_ko4. The PCR fragments were digested with <italic>Hind</italic>III/<italic>Bam</italic>HI and <italic>Bam</italic>HI/<italic>Eco</italic>RI, respectively, then ligated into pNPTS138, restricted with <italic>Hind</italic>III and <italic>Eco</italic>RI.</p></list-item><list-item><p>pNPTS<italic>_</italic>Δ<italic>00163</italic>: PCR was used to amplify two DNA fragments flanking the <italic>CCNA_00163</italic> ORF, by using primers 163_ko1/163_ko2 and 163_ko3/163_ko4. The PCR fragments were digested with <italic>Hind</italic>III/<italic>Bam</italic>HI and <italic>Bam</italic>HI/<italic>Eco</italic>RI, respectively, then ligated into pNPTS138, restricted with <italic>Hind</italic>III and <italic>Eco</italic>RI.</p></list-item><list-item><p>pNPTS<italic>_</italic>Δ<italic>00164</italic>: PCR was used to amplify two DNA fragments flanking the <italic>CCNA_00164</italic> ORF, by using primers 164_ko1/164_ko2 and 164_ko3/164_ko4. The PCR fragments were digested with <italic>Hind</italic>III/<italic>Bam</italic>HI and <italic>Bam</italic>HI/<italic>Eco</italic>RI, respectively, then ligated into pNPTS138, restricted with <italic>Hind</italic>III and <italic>Eco</italic>RI.</p></list-item><list-item><p>pNPTS<italic>_</italic>Δ<italic>hvyA</italic>: PCR was used to amplify two DNA fragments flanking the <italic>hvyA</italic> ORF, by using primers hvyA_ko1/hvyA_ko2 and hvyA_ko3/hvyA_ko4. The PCR fragments were digested with <italic>Eco</italic>RI/<italic>Bam</italic>HI and <italic>Bam</italic>HI/<italic>Hind</italic>III, respectively, then ligated into pNPTS138, restricted with <italic>Hind</italic>III and <italic>Eco</italic>RI.</p></list-item><list-item><p>pNPTS_P<sub><italic>hvyA</italic></sub><italic>-mCh::hvyA</italic>: primers hvyA_up_H and hvyA_up_B were used to amplify a 921-bp fragment encompassing the region upstream of <italic>hvyA</italic> and the first 78 bp of the <italic>hvyA</italic> ORF (encoding the signal sequence). Primers mCh_B and mCh_X were used to amplify the mCherry coding sequence (without ATG and stop codon). Primers hvyA_down_X and hvyA_down_E were used to amplify a 719-bp fragment of <italic>hvyA</italic> ORF. The three PCR fragments were digested with <italic>Hind</italic>III/<italic>Bam</italic>HI, <italic>Bam</italic>HI/<italic>Xba</italic>I, and <italic>Xba</italic>I/<italic>Eco</italic>RI, respectively, and ligated into pNPTS138, restricted with <italic>Hind</italic>III and <italic>Eco</italic>RI.</p></list-item><list-item><p>pNPTS<italic>_</italic>Δ<italic>00167</italic>: PCR was used to amplify two DNA fragments flanking the <italic>CCNA_00167</italic> ORF, by using primers 167_ko1/167_ko2 and 167_ko3/167_ko4. The PCR fragments were digested with <italic>Eco</italic>RI/<italic>Bam</italic>HI and <italic>Bam</italic>HI/<italic>Hind</italic>III, respectively, then ligated into pNPTS138, restricted with <italic>Hind</italic>III and <italic>Eco</italic>RI.</p></list-item><list-item><p>pNPTS<italic>_</italic>Δ<italic>00167</italic><sub>(Δ<italic>hvyA</italic>)</sub>: in order to obtain an in-frame deletion of <italic>CCNA_00167</italic> in the Δ<italic>hvyA</italic> background, primers 167_ko5/167_ko6 were used to amplify by PCR a 1085-bp fragment upstream of <italic>CCNA_00167</italic> (using genomic DNA of the Δ<italic>hvyA</italic> strain as template). The PCR fragment was digested with <italic>Eco</italic>RI/<italic>Bgl</italic>II and ligated into pNPTS<italic>_</italic>Δ<italic>00167,</italic> restricted with <italic>Bam</italic>HI and <italic>Eco</italic>RI.</p></list-item><list-item><p>pNPTS<italic>_</italic>Δ<italic>03998</italic>: PCR was used to amplify two DNA fragments flanking the <italic>CCNA_03998</italic> ORF, by using primers 3998_ko1/3998_ko2 and 3998_ko3/3998_ko4. The PCR fragments were digested with <italic>Eco</italic>RI/<italic>Bam</italic>HI and <italic>Bam</italic>HI/<italic>Hind</italic>III, respectively, then ligated into pNPTS138, restricted with <italic>Hind</italic>III and <italic>Eco</italic>RI.</p></list-item><list-item><p>pNPTS_Δ<italic>00466</italic>: PCR was used to amplify two DNA fragments flanking the <italic>CCNA_00466</italic> ORF, by using primers 466_ko1/466_ko2 and 466_ko3/466_ko4. The PCR fragments were digested with <italic>Mun</italic>I/<italic>Bam</italic>HI and <italic>Bam</italic>HI/<italic>Hind</italic>III, respectively, then ligated into pNPTS138, restricted with <italic>Hind</italic>III and <italic>Eco</italic>RI.</p></list-item><list-item><p>pNPTS_Δ<italic>00467</italic>: PCR was used to amplify two DNA fragments flanking the <italic>CCNA_00467</italic> ORF, by using primers 467_ko1/467_ko2 and 467_ko3/467_ko4. The PCR fragments were digested with <italic>Hind</italic>III/<italic>Bam</italic>HI and <italic>Bam</italic>HI/<italic>Eco</italic>RI, respectively, then ligated into pNPTS138, restricted with <italic>Hind</italic>III and <italic>Eco</italic>RI.</p></list-item><list-item><p>pNPTS_Δ<italic>00470</italic>: PCR was used to amplify two DNA fragments flanking the <italic>CCNA_00470</italic> ORF, by using primers 470_ko1/470_ko2 and 470_ko3/470_ko4. The PCR fragments were digested with <italic>Eco</italic>RI/<italic>Bam</italic>HI and <italic>Bam</italic>HI/<italic>Hind</italic>III, respectively, then ligated into pNPTS138, restricted with <italic>Hind</italic>III and <italic>Eco</italic>RI.</p></list-item><list-item><p>Bi-parental matings were used to transfer the resulting pNPTS138 derivatives into <italic>C. crescentus</italic> strains. Double recombination was selected by plating bacteria onto PYE plates containing 3% sucrose. Putative mutants were confirmed by PCR using primers external to the DNA fragments used for the pNPTS138 constructs.</p></list-item><list-item><p>To inactivate the <italic>rsaA</italic> gene in the Δ<italic>hvyA</italic>, Δ<italic>CCNA_00163</italic>, or Δ<italic>hvyA</italic> Δ<italic>CCNA_00163</italic> mutant strains, plasmid pNPTS138_Δ<italic>rsaA</italic> was introduced into the strains by bi-parental mating. Clones that had undergone a single recombination event were selected on PYE plates containing kanamycin and verified by PCR.</p></list-item><list-item><p>To created strain SA1984 (Δ<italic>mucR1</italic>Δ<italic>mucR2</italic> with <italic>hvyA</italic> replaced by N-terminal mCherry-tagged <italic>hvyA</italic>), a 719-bp fragment was amplified by PCR using primers hvyA_in_B and hvyA_E. The PCR fragment was digested with <italic>Bam</italic>HI/<italic>Eco</italic>RI and ligated into pGS18T, restricted with the same enzymes. The resulting plasmid (pSA480) was integrated into the <italic>hvyA</italic> locus in SA1737 (strain SA1951), and the <italic>mCh-hvyA</italic> fusion was transduced into the Δ<italic>mucR1</italic>Δ<italic>mucR2</italic> strain by φCr30-mediated transduction and selection on PYE kanamycin plates.</p></list-item><list-item><p>To create the P<sub><italic>hvyA</italic></sub><italic>-hvyA::lacZ</italic> translational fusion (pSA184), a 531-bp DNA fragment, encompassing 513-bp upstream of <italic>hvyA</italic> and the first six codon of <italic>hvyA</italic> ORF, was amplified by PCR with primers PhvyA_B/PhvyA_P, digested with <italic>Bgl</italic>II and <italic>Pst</italic>I, and ligated into pJC327 (<xref ref-type="bibr" rid="bib13">Chen et al., 2006</xref>), restricted with the same enzymes.</p></list-item><list-item><p>To create the P<sub><italic>hvyA</italic></sub><italic>-lacZ</italic> transcriptional fusion (pSA205), the fragment corresponding to the <italic>hvyA</italic> promoter region was excised from pSA184 with <italic>Bgl</italic>II and <italic>Pst</italic>I, and ligated into pRKlac290 (<xref ref-type="bibr" rid="bib28">Gober and Shapiro, 1992</xref>), cut with <italic>Bam</italic>HI and <italic>Pst</italic>I.</p></list-item><list-item><p>To create the P<sub><italic>SMc00998</italic></sub><italic>-lacZ</italic> transcriptional fusion (pSA146), a 542-bp DNA fragment was amplified by PCR with primers Sm998_B/Sm998_P from <italic>S. meliloti</italic> genomic DNA, digested with <italic>Bam</italic>HI and <italic>Pst</italic>I, and ligated into pRKlac290, cut with the same enzymes.</p></list-item><list-item><p>Plasmids for β-galactosidase assays were introduced into <italic>S. meliloti</italic> Rm2011 and Rm101 by bi-parental mating.</p></list-item><list-item><p>To complement the Δ<italic>hvyA</italic> mutation, the <italic>hvyA</italic> ORF was amplified by PCR with primers hvyA_N and hvyA_E. The resulting PCR product was digested with <italic>Nde</italic>I and <italic>EcoR</italic>I and ligated into pMT335 (P<sub><italic>van</italic></sub>, medium copy plasmid; pMT335-<italic>hvyA</italic>) or pMT375 (<xref ref-type="bibr" rid="bib67">Thanbichler et al., 2007</xref>) (P<sub><italic>xyl</italic></sub>, low copy plasmid; pMT375-<italic>hvyA</italic>), restricted with the same enzymes.</p></list-item><list-item><p>To create the P<sub><italic>van</italic></sub>-<italic>hvyA-TAP</italic> fusion (plasmid pUG52), the <italic>hvyA</italic> ORF was amplified by PCR with primers hvyA_N and hvyA_CTIF (without stop codon). The PCR fragment was digested with <italic>Nde</italic>I and <italic>Eco</italic>RI and cloned into a pMT335 derivative harbouring the TAP epitope cloned as <italic>EcoR</italic>I/<italic>Xba</italic>I fragment (<xref ref-type="bibr" rid="bib53">Radhakrishnan et al., 2010</xref>).</p></list-item></list></p><p>Plasmids to complement the in-frame deletion mutants and for over-expression (from P<sub><italic>van</italic></sub>) were constructed as follows:<list list-type="simple"><list-item><p>pSA362: <italic>CCNA_00162</italic> ORF was amplified by PCR with primers 162_N (with <italic>Nde</italic>I site overlapping the start codon) and 162_M (with <italic>Mun</italic>I site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pSA361: <italic>CCNA_00163</italic> ORF was amplified by PCR with primers 163_N (with <italic>Nde</italic>I site overlapping the start codon) and 163_E (with <italic>Eco</italic>RI site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pSA401: <italic>CCNA_00164</italic> ORF was amplified by PCR with primers 164_N (with <italic>Nde</italic>I site overlapping the start codon) and 164_E (with <italic>Eco</italic>RI site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pSA62: <italic>CCNA_00167</italic> ORF was amplified by PCR with primers 167_N (with <italic>Nde</italic>I site overlapping the start codon) and 167_E (with <italic>Eco</italic>RI site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pSA324: <italic>CCNA_00168</italic> ORF was amplified by PCR with primers 168_N (with <italic>Nde</italic>I site overlapping the start codon) and 168_E (with <italic>Eco</italic>RI site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pUG35: <italic>CCNA_03998</italic> ORF was amplified by PCR with primers 3998_N (with <italic>Nde</italic>I site overlapping the start codon) and 3998_E (with <italic>Eco</italic>RI site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pUG28: <italic>CCNA_00466</italic> ORF was amplified by PCR with primers 466_N (with <italic>Nde</italic>I site overlapping the start codon) and 466_M (with <italic>Mun</italic>I site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pSA102: <italic>CCNA_00470</italic> ORF was amplified by PCR with primers 470_N (with <italic>Nde</italic>I site overlapping the start codon) and 470_E (with <italic>Eco</italic>RI site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pSA264: <italic>SMc00998</italic> ORF was amplified by PCR from <italic>S. meliloti</italic> genomic DNA with primers Sm998_N (with <italic>Nde</italic>I site overlapping the start codon) and Sm998_E (with <italic>Eco</italic>RI site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pSA142: <italic>NGR_c12490</italic> ORF was amplified by PCR from <italic>S. fredii</italic> NGR234 genomic DNA with primers Sf12490_N (with <italic>Nde</italic>I site overlapping the start codon) and Sf12490_M (with <italic>Mun</italic>I site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pSA141: <italic>NGR_c19800</italic> ORF was amplified by PCR from <italic>S. fredii</italic> NGR234 genomic DNA with primers Sf19800_N (with <italic>Nde</italic>I site overlapping the start codon) and Sf19800_E (with <italic>Eco</italic>RI site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pSA147: <italic>NGR_c36180</italic> ORF was amplified by PCR from <italic>S. fredii</italic> NGR234 genomic DNA with primers Sf36180_N (with <italic>Nde</italic>I site overlapping the start codon) and Sf36180_E (with <italic>Eco</italic>RI site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pSA309: <italic>Atu0252</italic> ORF was amplified by PCR from <italic>A. tumefaciens</italic> genomic DNA with primers At252_N (with <italic>Nde</italic>I site overlapping the start codon) and At252_E (with <italic>Eco</italic>RI site flanking the stop codon) and cloned into pMT335, restricted with <italic>Nde</italic>I and <italic>Eco</italic>RI.</p></list-item><list-item><p>pMT335-<italic>Bh_MucR</italic>: a synthetic fragment encoding the <italic>mucR</italic> homolog from <italic>Bartonella henselae</italic> (<italic>PRJBM_00467</italic>) was ligated into pMT335 (using <italic>Nde</italic>I/<italic>Eco</italic>RI).</p></list-item></list></p><p>Synthetic DNA fragment (Integrated DNA Technologies) encoding <italic>PRJBM_00467</italic> (codon optimized for <italic>C. crescentus</italic>) (5′–3′):</p><p><italic><underline>CATATG</underline></italic>GAGCACCGACCGGTGCTGGAAACCGAGTCGAATCTGGTCATCACCCTCGTCGCCGACATCGTCGCCGCGTATGTGTCGAACAACTCCATCCGTCCCACCGAGGTCCCCAGCCTCATCGCGGACGTCCATGCGGCTTTCCGCAAGGCCGGCAACGCCGACTTGACGGAAGTTGAGGTGGAGAAGCAGCGCCCTGCGGTCAACCCGAAGCGCAGCATCTTCCCGGACTACCTTATCTGCCTGGAAGATGGCAAGAAGTTCAAGAGCCTGAAGCGCCACCTGATGACGCACTATGGCATGCTGCCGGAAGAGTATCGCGAGAAGTGGCAGCTGGACTCTTCGTACCCCATGGTGGCCCCGAACTACGCGAAGGCCCGGTCGGCCCTGGCCAAAGAGATGGGCCTGGGGCGGAAGTCCAAGCGGAAAAAGACCAAGT<italic><underline>GAATTC</underline></italic><list list-type="simple"><list-item><p>Plasmid pSA354 is a derivative of pCWR547 (<xref ref-type="bibr" rid="bib53">Radhakrishnan et al., 2010</xref>) expressing His<sub>6</sub>-SUMO-CCNA_00162<sub>(51-422)</sub> under the control of the T7 promoter. To construct pSA354, a fragment encoding residues 51-422 of CCNA_00162 was amplified by PCR with primers 162_in_N and 162_in_S, digested with <italic>Nde</italic>I and <italic>Sac</italic>I, and cloned into pCWR547, restricted with the same enzymes.</p></list-item><list-item><p>Plasmid pCWR508 is a derivative of pET-47b (Novagen) expressing CCNA_00163<sub>(101-300)</sub>-His<sub>6</sub> under the control of the T7 promoter. To construct pCWR508, a fragment encoding residues 101-300 of CCNA_00163 was amplified by PCR with primers 163_in_N and 163_His_E (that also encodes six His residues followed by a stop codon and Eco<italic>RI</italic> site), digested with <italic>Nde</italic>I and <italic>Eco</italic>RI, and cloned into pET47b, restricted with the same enzymes.</p></list-item><list-item><p>Plasmid pSA352 is a derivative of pCWR547 expressing His<sub>6</sub>-SUMO-CCNA_00164<sub>(481-620)</sub> under control of the T7 promoter. To construct pSA352, a fragment encoding residues 481-620 of CCNA_00164 was amplified by PCR with primers 164_in_N and 164_in_S, digested with <italic>Nde</italic>I and <italic>Sac</italic>I, and cloned into pCWR547, restricted with the same enzymes.</p></list-item><list-item><p>Plasmid pET-<italic>hvyA</italic> is a derivative of pET-28a (Novagen) expressing His<sub>6</sub>-HvyA<sub>(26-272)</sub> under the control of the T7 promoter. To construct pET-hvyA, a fragment encoding residues 26-272 of HvyA was amplified by PCR with primers hvyA_short and hvyA_E, digested with <italic>Nde</italic>I and <italic>Eco</italic>RI and cloned into pET-28, restricted with the same enzymes.</p></list-item><list-item><p>Plasmid pET-<italic>00167</italic> is a derivative of pET-28a expressing His<sub>6</sub>-CCNA_00167<sub>(1-108)</sub> under the control of the T7 promoter. To construct pET-00167, a fragment encoding residues 1-208 of CCNA_00167 was amplified by PCR with primers 167_N and 167_in_E, digested with <italic>Nde</italic>I and <italic>Eco</italic>RI, and cloned into pET-28, restricted with the same enzymes.</p></list-item><list-item><p>Plasmid pSA342 is a derivative of pCWR547 expressing His<sub>6</sub>-SUMO-CCNA_00168<sub>(41-198)</sub> under the control of the T7 promoter. To construct pSA342, a fragment encoding residues 41-198 of CCNA_00168 was amplified by PCR with primers 168_short and 168_E, digested with <italic>Nde</italic>I and <italic>Eco</italic>RI, and cloned into pET-28. The CCNA_00168 fragment was then sub-cloned into pCWR547 using <italic>Nde</italic>I/<italic>Sac</italic>I.</p></list-item><list-item><p>Plasmid pCWR496 is a derivative of pET-47b expressing CCNA_02223<sub>(22-289)</sub>-His<sub>6</sub> under control of the T7 promoter. To construct pCWR496, a fragment encoding residues 22-289 of CCNA_02223 (β-lactamase) was amplified by PCR with primers bla_N and bla_His_E (that also encodes six His residues followed by a stop codon and <italic>Eco</italic>RI site), digested with <italic>Nde</italic>I and <italic>Eco</italic>RI, and cloned into pET47b, restricted with t<italic>h</italic>e same enzymes.</p></list-item></list></p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>Support is from SNF grant #31003A_143660 and grant A/C ME9175 from the Synapsis Foundation and the Stammbach-Stiftung to PV. Work at the Université catholique de Louvain was supported by the National Fund for Scientific Research (FNRS), the Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme), and the Research Department of the Communauté française de Belgique (Concerted Research Action), Y.F.D. is a Research Director of the FNRS. We thank Melissa Marks and Urs Jenal for communicating results prior to publication and Yves Brun for sending the pNPTS_Δ<italic>pssY</italic> plasmid. We thank Antonio Frandi, Haleh Yasrebi, and Gaël Panis for their help with the Tn-seq analysis. This research was supported in part by the Department of Energy grant Plant and Microbial Complex Carbohydrates (DE-FG02-93ER20097) to Parastoo Azadi at the Complex Carbohydrate Research Center.</p></ack><sec sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>SA, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con2"><p>PHV, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con3"><p>CF, Conception and design, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con4"><p>MB, Conception and design, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con5"><p>SKR, Conception and design, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con6"><p>AB, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con7"><p>LT, Contributed to all molecular biology steps (e.g. cloning), construction of mutant strains and beta-galactosidase assays, Acquisition of data</p></fn><fn fn-type="con" id="con8"><p>YFD, Conception and design, Analysis and interpretation of data</p></fn></fn-group></sec><sec sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="SD2-data"><object-id pub-id-type="doi">10.7554/eLife.03587.029</object-id><label>Supplementary file 1.</label><caption><p>Phenotypes of <italic>WT Caulobacter</italic> and mutant strains.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.029">http://dx.doi.org/10.7554/eLife.03587.029</ext-link></p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-03587-supp1-v1.docx"/></supplementary-material><supplementary-material id="SD3-data"><object-id pub-id-type="doi">10.7554/eLife.03587.030</object-id><label>Supplementary file 2.</label><caption><p>Nucleotide position of <italic>himar1</italic> insertions.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.030">http://dx.doi.org/10.7554/eLife.03587.030</ext-link></p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-03587-supp2-v1.docx"/></supplementary-material><supplementary-material id="SD4-data"><object-id pub-id-type="doi">10.7554/eLife.03587.031</object-id><label>Supplementary file 3.</label><caption><p>Strains used in this study.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.031">http://dx.doi.org/10.7554/eLife.03587.031</ext-link></p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-03587-supp3-v1.docx"/></supplementary-material><supplementary-material id="SD5-data"><object-id pub-id-type="doi">10.7554/eLife.03587.032</object-id><label>Supplementary file 4.</label><caption><p>Plasmids used in this study.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.032">http://dx.doi.org/10.7554/eLife.03587.032</ext-link></p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-03587-supp4-v1.docx"/></supplementary-material><supplementary-material id="SD6-data"><object-id pub-id-type="doi">10.7554/eLife.03587.033</object-id><label>Supplementary file 5.</label><caption><p>Oligonucleotides used in this study.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.033">http://dx.doi.org/10.7554/eLife.03587.033</ext-link></p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-03587-supp5-v1.docx"/></supplementary-material><supplementary-material id="SD7-data"><object-id pub-id-type="doi">10.7554/eLife.03587.034</object-id><label>Supplementary file 6.</label><caption><p>Global Tn-insertion values for the Tn-Seq experiment.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03587.034">http://dx.doi.org/10.7554/eLife.03587.034</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-03587-supp6-v1.xlsx"/></supplementary-material></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardissone</surname><given-names>S</given-names></name><name><surname>Viollier</surname><given-names>PH</given-names></name></person-group><year>2012</year><article-title>Developmental and environmental regulatory pathways in alpha-proteobacteria</article-title><source>Frontiers in bioscience</source><volume>17</volume><fpage>1695</fpage><lpage>1714</lpage><pub-id pub-id-type="doi">10.2741/4013</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awram</surname><given-names>P</given-names></name><name><surname>Smit</surname><given-names>J</given-names></name></person-group><year>1998</year><article-title>The <italic>Caulobacter</italic> crescentus paracrystalline S-layer protein is secreted by an ABC transporter (type I) secretion apparatus</article-title><source>Journal of Bacteriology</source><volume>180</volume><fpage>3062</fpage><lpage>3069</lpage></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>A</given-names></name><name><surname>Rüberg</surname><given-names>S</given-names></name><name><surname>Küster</surname><given-names>H</given-names></name><name><surname>Roxlau</surname><given-names>AA</given-names></name><name><surname>Keller</surname><given-names>M</given-names></name><name><surname>Ivashina</surname><given-names>T</given-names></name><name><surname>Cheng</surname><given-names>HP</given-names></name><name><surname>Walker</surname><given-names>GC</given-names></name><name><surname>Pühler</surname><given-names>A</given-names></name></person-group><year>1997</year><article-title>The 32-kilobase exp gene cluster of <italic>Rhizobium meliloti</italic> directing the biosynthesis of galactoglucan: genetic organization and properties of the encoded gene products</article-title><source>Journal of Bacteriology</source><volume>179</volume><fpage>1375</fpage><lpage>1384</lpage></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergé</surname><given-names>MJ</given-names></name><name><surname>Kamgoue</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>B</given-names></name><name><surname>Polard</surname><given-names>P</given-names></name><name><surname>Campo</surname><given-names>N</given-names></name><name><surname>Claverys</surname><given-names>JP</given-names></name></person-group><year>2013</year><article-title>Midcell recruitment of the DNA uptake and virulence nuclease, EndA, for pneumococcal transformation</article-title><source>PLOS Pathogens</source><volume>9</volume><fpage>e1003596</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1003596</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biondi</surname><given-names>EG</given-names></name><name><surname>Reisinger</surname><given-names>SJ</given-names></name><name><surname>Skerker</surname><given-names>JM</given-names></name><name><surname>Arif</surname><given-names>M</given-names></name><name><surname>Perchuk</surname><given-names>BS</given-names></name><name><surname>Ryan</surname><given-names>KR</given-names></name><name><surname>Laub</surname><given-names>MT</given-names></name></person-group><year>2006</year><article-title>Regulation of the bacterial cell cycle by an integrated genetic circuit</article-title><source>Nature</source><volume>444</volume><fpage>899</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1038/nature05321</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>KM</given-names></name><name><surname>Turner</surname><given-names>L</given-names></name><name><surname>Winkelman</surname><given-names>JT</given-names></name><name><surname>Berg</surname><given-names>HC</given-names></name><name><surname>Kearns</surname><given-names>DB</given-names></name></person-group><year>2008</year><article-title>A molecular clutch disables flagella in the <italic>Bacillus subtilis</italic> biofilm</article-title><source>Science</source><volume>320</volume><fpage>1636</fpage><lpage>1638</lpage><pub-id pub-id-type="doi">10.1126/science.1157877</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>CD</given-names></name><name><surname>Chatterjee</surname><given-names>D</given-names></name><name><surname>Sondermann</surname><given-names>H</given-names></name><name><surname>O'Toole</surname><given-names>GA</given-names></name></person-group><year>2012</year><article-title>LapG, required for modulating biofilm formation by <italic>Pseudomonas fluorescens</italic> Pf0-1, is a calcium-dependent protease</article-title><source>Journal of Bacteriology</source><volume>194</volume><fpage>4406</fpage><lpage>4414</lpage><pub-id pub-id-type="doi">10.1128/JB.00642-12</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brilli</surname><given-names>M</given-names></name><name><surname>Fondi</surname><given-names>M</given-names></name><name><surname>Fani</surname><given-names>R</given-names></name><name><surname>Mengoni</surname><given-names>A</given-names></name><name><surname>Ferri</surname><given-names>L</given-names></name><name><surname>Bazzicalupo</surname><given-names>M</given-names></name><name><surname>Biondi</surname><given-names>EG</given-names></name></person-group><year>2010</year><article-title>The diversity and evolution of cell cycle regulation in alpha-proteobacteria: a comparative genomic analysis</article-title><source>BMC Systems Biology</source><volume>4</volume><fpage>52</fpage><pub-id pub-id-type="doi">10.1186/1752-0509-4-52</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casse</surname><given-names>F</given-names></name><name><surname>Boucher</surname><given-names>C</given-names></name><name><surname>Julliot</surname><given-names>JS</given-names></name><name><surname>Michel</surname><given-names>M</given-names></name><name><surname>Dénarié</surname><given-names>J</given-names></name></person-group><year>1979</year><article-title>Identification and characterization of large plasmids in <italic>Rhizobium meliloti</italic> using agarose gel electrophoresis</article-title><source>Nature Reviews Microbiology</source><volume>113</volume><fpage>229</fpage><lpage>242</lpage></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name></person-group><year>2011</year><article-title>Optimization of fixation methods for observation of bacterial cell morphology and surface ultrastructures by atomic force microscopy</article-title><source>Applied Microbiology and Biotechnology</source><volume>92</volume><fpage>381</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1007/s00253-011-3551-5</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>D</given-names></name><name><surname>Boyd</surname><given-names>CD</given-names></name><name><surname>O'Toole</surname><given-names>GA</given-names></name><name><surname>Sondermann</surname><given-names>H</given-names></name></person-group><year>2012</year><article-title>Structural characterization of a conserved, calcium-dependent periplasmic protease from <italic>Legionella pneumophila</italic></article-title><source>Journal of Bacteriology</source><volume>194</volume><fpage>4415</fpage><lpage>4425</lpage><pub-id pub-id-type="doi">10.1128/JB.00640-12</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JC</given-names></name><name><surname>Viollier</surname><given-names>PH</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>2005</year><article-title>A membrane metalloprotease participates in the sequential degradation of a <italic>Caulobacter</italic> polarity determinant</article-title><source>Molecular Microbiology</source><volume>55</volume><fpage>1085</fpage><lpage>1103</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04443.x</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JC</given-names></name><name><surname>Hottes</surname><given-names>AK</given-names></name><name><surname>McAdams</surname><given-names>HH</given-names></name><name><surname>McGrath</surname><given-names>PT</given-names></name><name><surname>Viollier</surname><given-names>PH</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>2006</year><article-title>Cytokinesis signals truncation of the PodJ polarity factor by a cell cycle-regulated protease</article-title><source>The EMBO Journal</source><volume>25</volume><fpage>377</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600935</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christen</surname><given-names>B</given-names></name><name><surname>Abeliuk</surname><given-names>E</given-names></name><name><surname>Collier</surname><given-names>JM</given-names></name><name><surname>Kalogeraki</surname><given-names>VS</given-names></name><name><surname>Passarelli</surname><given-names>B</given-names></name><name><surname>Coller</surname><given-names>JA</given-names></name><name><surname>Fero</surname><given-names>MJ</given-names></name><name><surname>McAdams</surname><given-names>HH</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>2011</year><article-title>The essential genome of a bacterium</article-title><source>Molecular Systems Biology</source><volume>7</volume><fpage>528</fpage><pub-id pub-id-type="doi">10.1038/msb.2011.58</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>RF</given-names></name><name><surname>Derrick</surname><given-names>JP</given-names></name></person-group><year>2007</year><article-title>Wza: a new structural paradigm for outer membrane secretory proteins?</article-title><source>Trends in Microbiology</source><volume>15</volume><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2007.01.002</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname><given-names>PD</given-names></name><name><surname>Brun</surname><given-names>YV</given-names></name></person-group><year>2010</year><article-title>Getting in the loop: regulation of development in Caulobacter crescentus</article-title><source>Microbiology and Molecular Biology Reviews</source><volume>74</volume><fpage>13</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00040-09</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dague</surname><given-names>E</given-names></name><name><surname>Alsteens</surname><given-names>D</given-names></name><name><surname>Latge</surname><given-names>JP</given-names></name><name><surname>Dufrêne</surname><given-names>YF</given-names></name></person-group><year>2008</year><article-title>High-resolution cell surface dynamics of germinating <italic>Aspergillus fumigatus</italic> conidia</article-title><source>Biophysical Journal</source><volume>94</volume><fpage>656</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1529/biophysj.107.116491</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Nisco</surname><given-names>NJ</given-names></name><name><surname>Abo</surname><given-names>RP</given-names></name><name><surname>Wu</surname><given-names>CM</given-names></name><name><surname>Penterman</surname><given-names>J</given-names></name><name><surname>Walker</surname><given-names>GC</given-names></name></person-group><year>2014</year><article-title>Global analysis of cell cycle gene expression of the legume symbiont <italic>Sinorhizobium meliloti</italic></article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>111</volume><fpage>3217</fpage><lpage>3224</lpage><pub-id pub-id-type="doi">10.1073/pnas.1400421111</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domian</surname><given-names>IJ</given-names></name><name><surname>Quon</surname><given-names>KC</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>1997</year><article-title>Cell type-specific phosphorylation and proteolysis of a transcriptional regulator controls the G1-to-S transition in a bacterial cell cycle</article-title><source>Cell</source><volume>90</volume><fpage>415</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80502-4</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Souza</surname><given-names>JM</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Reeves</surname><given-names>P</given-names></name></person-group><year>2002</year><article-title>Sequence of the <italic>Escherichia coli</italic> O26 O antigen gene cluster and identification of O26 specific genes</article-title><source>Gene</source><volume>297</volume><fpage>123</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/S0378-1119(02)00876-4</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dufrêne</surname><given-names>YF</given-names></name></person-group><year>2014</year><article-title>Atomic force microscopy in microbiology: new structural and functional insights into the microbial cell surface</article-title><source>mBio</source><volume>5</volume><fpage>e01363</fpage><lpage>e01314</lpage><pub-id pub-id-type="doi">10.1128/mBio.01363-14</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>P</given-names></name><name><surname>Smit</surname><given-names>J</given-names></name></person-group><year>1991</year><article-title>A transducing bacteriophage for <italic>Caulobacter crescentus</italic> uses the paracrystalline surface layer protein as a receptor</article-title><source>Journal of Bacteriology</source><volume>173</volume><fpage>5568</fpage><lpage>5572</lpage></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ely</surname><given-names>B</given-names></name></person-group><year>1991</year><article-title>Genetics of Caulobacter crescentus</article-title><source>Methods in Enzymology</source><volume>204</volume><fpage>372</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(91)04019-K</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evinger</surname><given-names>M</given-names></name><name><surname>Agabian</surname><given-names>N</given-names></name></person-group><year>1977</year><article-title>Envelope-associated nucleoid from <italic>Caulobacter crescentus</italic> stalked and swarmer cells</article-title><source>Journal of Bacteriology</source><volume>132</volume><fpage>294</fpage><lpage>301</lpage></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fumeaux</surname><given-names>C</given-names></name><name><surname>Radhakrishnan</surname><given-names>SK</given-names></name><name><surname>Ardissone</surname><given-names>S</given-names></name><name><surname>Théraulaz</surname><given-names>L</given-names></name><name><surname>Frandi</surname><given-names>A</given-names></name><name><surname>Martins</surname><given-names>D</given-names></name><name><surname>Nesper</surname><given-names>J</given-names></name><name><surname>Abel</surname><given-names>S</given-names></name><name><surname>Jenal</surname><given-names>U</given-names></name><name><surname>Viollier</surname><given-names>PH</given-names></name></person-group><year>2014</year><article-title>Cell cycle transition from S-phase to G1 in <italic>Caulobacter</italic> is mediated by ancestral virulence regulators</article-title><source>Nature Communications</source><volume>5</volume><fpage>4081</fpage><pub-id pub-id-type="doi">10.1038/ncomms5081</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gates</surname><given-names>MA</given-names></name><name><surname>Thorkildson</surname><given-names>P</given-names></name><name><surname>Kozel</surname><given-names>TR</given-names></name></person-group><year>2004</year><article-title>Molecular architecture of the <italic>Cryptococcus neoformans</italic> capsule</article-title><source>Molecular Microbiology</source><volume>52</volume><fpage>13</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2003.03957.x</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginalski</surname><given-names>K</given-names></name><name><surname>Kinch</surname><given-names>L</given-names></name><name><surname>Rychlewski</surname><given-names>L</given-names></name><name><surname>Grishin</surname><given-names>NV</given-names></name></person-group><year>2004</year><article-title>BTLCP proteins: a novel family of bacterial transglutaminase-like cysteine proteinases</article-title><source>Trends in Biochemical Sciences</source><volume>29</volume><fpage>392</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2004.06.001</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gober</surname><given-names>JW</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>1992</year><article-title>A developmentally regulated <italic>Caulobacter</italic> flagellar promoter is activated by 3' enhancer and IHF binding elements</article-title><source>Molecular Biology of the Cell</source><volume>3</volume><fpage>913</fpage><lpage>926</lpage><pub-id pub-id-type="doi">10.1091/mbc.3.8.913</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gora</surname><given-names>KG</given-names></name><name><surname>Tsokos</surname><given-names>CG</given-names></name><name><surname>Chen</surname><given-names>YE</given-names></name><name><surname>Srinivasan</surname><given-names>BS</given-names></name><name><surname>Perchuk</surname><given-names>BS</given-names></name><name><surname>Laub</surname><given-names>MT</given-names></name></person-group><year>2010</year><article-title>A cell-type-specific protein-protein interaction modulates transcriptional activity of a master regulator in <italic>Caulobacter crescentus</italic></article-title><source>Molecular Cell</source><volume>39</volume><fpage>455</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.06.024</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallez</surname><given-names>R</given-names></name><name><surname>Bellefontaine</surname><given-names>AF</given-names></name><name><surname>Letesson</surname><given-names>JJ</given-names></name><name><surname>De Bolle</surname><given-names>X</given-names></name></person-group><year>2004</year><article-title>Morphological and functional asymmetry in alpha-proteobacteria</article-title><source>Trends in Microbiology</source><volume>12</volume><fpage>361</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2004.06.002</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hathaway</surname><given-names>LJ</given-names></name><name><surname>Brugger</surname><given-names>SD</given-names></name><name><surname>Morand</surname><given-names>B</given-names></name><name><surname>Bangert</surname><given-names>M</given-names></name><name><surname>Rotzetter</surname><given-names>JU</given-names></name><name><surname>Hauser</surname><given-names>C</given-names></name><name><surname>Graber</surname><given-names>WA</given-names></name><name><surname>Gore</surname><given-names>S</given-names></name><name><surname>Kadioglu</surname><given-names>A</given-names></name><name><surname>Mühlemann</surname><given-names>K</given-names></name></person-group><year>2012</year><article-title>Capsule type of <italic>Streptococcus pneumoniae</italic> determines growth phenotype</article-title><source>PLOS Pathogens</source><volume>8</volume><fpage>e1002574</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002574</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname><given-names>P</given-names></name><name><surname>Abedon</surname><given-names>ST</given-names></name></person-group><year>2010</year><article-title>Bacteriophage host range and bacterial resistance</article-title><source>Advances in Applied Microbiology</source><volume>70</volume><fpage>217</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1016/S0065-2164(10)70007-1</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iniesta</surname><given-names>AA</given-names></name><name><surname>McGrath</surname><given-names>PT</given-names></name><name><surname>Reisenauer</surname><given-names>A</given-names></name><name><surname>McAdams</surname><given-names>HH</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>2006</year><article-title>A phospho-signaling pathway controls the localization and activity of a protease complex critical for bacterial cell cycle progression</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>103</volume><fpage>10935</fpage><lpage>10940</lpage><pub-id pub-id-type="doi">10.1073/pnas.0604554103</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarrell</surname><given-names>KF</given-names></name><name><surname>McBride</surname><given-names>MJ</given-names></name></person-group><year>2008</year><article-title>The surprisingly diverse ways that prokaryotes move</article-title><source>Nature Reviews Microbiology</source><volume>6</volume><fpage>466</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1900</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadioglu</surname><given-names>A</given-names></name><name><surname>Weiser</surname><given-names>JN</given-names></name><name><surname>Paton</surname><given-names>JC</given-names></name><name><surname>Andrew</surname><given-names>PW</given-names></name></person-group><year>2008</year><article-title>The role of <italic>Streptococcus pneumoniae</italic> virulence factors in host respiratory colonization and disease</article-title><source>Nature Reviews Microbiology</source><volume>6</volume><fpage>288</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1871</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>H</given-names></name><name><surname>De Nisco</surname><given-names>NJ</given-names></name><name><surname>Chien</surname><given-names>P</given-names></name><name><surname>Simmons</surname><given-names>LA</given-names></name><name><surname>Walker</surname><given-names>GC</given-names></name></person-group><year>2009</year><article-title><italic>Sinorhizobium meliloti</italic> CpdR1 is critical for co-ordinating cell cycle progression and the symbiotic chronic infection</article-title><source>Molecular Microbiology</source><volume>73</volume><fpage>586</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.06794.x</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laub</surname><given-names>MT</given-names></name><name><surname>McAdams</surname><given-names>HH</given-names></name><name><surname>Feldblyum</surname><given-names>T</given-names></name><name><surname>Fraser</surname><given-names>CM</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>2000</year><article-title>Global analysis of the genetic network controlling a bacterial cell cycle</article-title><source>Science</source><volume>290</volume><fpage>2144</fpage><lpage>2148</lpage><pub-id pub-id-type="doi">10.1126/science.290.5499.2144</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laub</surname><given-names>MT</given-names></name><name><surname>Chen</surname><given-names>SL</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name><name><surname>McAdams</surname><given-names>HH</given-names></name></person-group><year>2002</year><article-title>Genes directly controlled by CtrA, a master regulator of the <italic>Caulobacter</italic> cell cycle</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>99</volume><fpage>4632</fpage><lpage>4637</lpage><pub-id pub-id-type="doi">10.1073/pnas.062065699</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laubacher</surname><given-names>ME</given-names></name><name><surname>Ades</surname><given-names>SE</given-names></name></person-group><year>2008</year><article-title>The Rcs phosphorelay is a cell envelope stress response activated by peptidoglycan stress and contributes to intrinsic antibiotic resistance</article-title><source>Journal of Bacteriology</source><volume>190</volume><fpage>2065</fpage><lpage>2074</lpage><pub-id pub-id-type="doi">10.1128/JB.01740-07</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname><given-names>E</given-names></name><name><surname>Kugelberg</surname><given-names>E</given-names></name><name><surname>Tracy</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Gollan</surname><given-names>B</given-names></name><name><surname>Ewles</surname><given-names>H</given-names></name><name><surname>Chalmers</surname><given-names>R</given-names></name><name><surname>Pelicic</surname><given-names>V</given-names></name><name><surname>Tang</surname><given-names>CM</given-names></name></person-group><year>2013</year><article-title>Temperature triggers immune evasion by Neisseria meningitidis</article-title><source>Nature</source><volume>502</volume><fpage>237</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1038/nature12616</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorand</surname><given-names>L</given-names></name><name><surname>Graham</surname><given-names>RM</given-names></name></person-group><year>2003</year><article-title>Transglutaminases: crosslinking enzymes with pleiotropic functions</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>4</volume><fpage>140</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1038/nrm1014</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marks</surname><given-names>ME</given-names></name><name><surname>Castro-Rojas</surname><given-names>CM</given-names></name><name><surname>Teiling</surname><given-names>C</given-names></name><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Kapatral</surname><given-names>V</given-names></name><name><surname>Walunas</surname><given-names>TL</given-names></name><name><surname>Crosson</surname><given-names>S</given-names></name></person-group><year>2010</year><article-title>The genetic basis of laboratory adaptation in Caulobacter crescentus</article-title><source>Journal of Bacteriology</source><volume>192</volume><fpage>3678</fpage><lpage>3688</lpage><pub-id pub-id-type="doi">10.1128/JB.00255-10</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merkle</surname><given-names>RK</given-names></name><name><surname>Poppe</surname><given-names>I</given-names></name></person-group><year>1994</year><article-title>Carbohydrate composition analysis of glycoconjugates by gas-liquid chromatography/mass spectrometry</article-title><source>Methods in Enzymology</source><volume>230</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(94)30003-8</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>SM</given-names></name><name><surname>Panis</surname><given-names>G</given-names></name><name><surname>Fumeaux</surname><given-names>C</given-names></name><name><surname>Viollier</surname><given-names>PH</given-names></name><name><surname>Howard</surname><given-names>M</given-names></name></person-group><year>2013</year><article-title>Computational and genetic reduction of a cell cycle to its simplest, primordial components</article-title><source>PLOS Biology</source><volume>11</volume><fpage>e1001749</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.1001749</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>MV</given-names></name><name><surname>Newell</surname><given-names>PD</given-names></name><name><surname>Krasteva</surname><given-names>PV</given-names></name><name><surname>Chatterjee</surname><given-names>D</given-names></name><name><surname>Madden</surname><given-names>DR</given-names></name><name><surname>O'Toole</surname><given-names>GA</given-names></name><name><surname>Sondermann</surname><given-names>H</given-names></name></person-group><year>2011</year><article-title>Structural basis for c-di-GMP-mediated inside-out signaling controlling periplasmic proteolysis</article-title><source>PLOS Biology</source><volume>9</volume><fpage>e1000588</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.1000588.</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newell</surname><given-names>PD</given-names></name><name><surname>Monds</surname><given-names>RD</given-names></name><name><surname>O'Toole</surname><given-names>GA</given-names></name></person-group><year>2009</year><article-title>LapD is a bis-(3',5')-cyclic dimeric GMP-binding protein that regulates surface attachment by <italic>Pseudomonas fluorescens</italic> Pf0-1</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>106</volume><fpage>3461</fpage><lpage>3466</lpage><pub-id pub-id-type="doi">10.1073/pnas.0808933106</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newell</surname><given-names>PD</given-names></name><name><surname>Boyd</surname><given-names>CD</given-names></name><name><surname>Sondermann</surname><given-names>H</given-names></name><name><surname>O'Toole</surname><given-names>GA</given-names></name></person-group><year>2011</year><article-title>A c-di-GMP effector system controls cell adhesion by inside-out signaling and surface protein cleavage</article-title><source>PLOS Biology</source><volume>9</volume><fpage>e1000587</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.1000587</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pini</surname><given-names>F</given-names></name><name><surname>Frage</surname><given-names>B</given-names></name><name><surname>Ferri</surname><given-names>L</given-names></name><name><surname>De Nisco</surname><given-names>NJ</given-names></name><name><surname>Mohapatra</surname><given-names>SS</given-names></name><name><surname>Taddei</surname><given-names>L</given-names></name><name><surname>Fioravanti</surname><given-names>A</given-names></name><name><surname>Dewitte</surname><given-names>F</given-names></name><name><surname>Galardini</surname><given-names>M</given-names></name><name><surname>Brilli</surname><given-names>M</given-names></name><name><surname>Villeret</surname><given-names>V</given-names></name><name><surname>Bazzicalupo</surname><given-names>M</given-names></name><name><surname>Mengoni</surname><given-names>A</given-names></name><name><surname>Walker</surname><given-names>GC</given-names></name><name><surname>Becker</surname><given-names>A</given-names></name><name><surname>Biondi</surname><given-names>EG</given-names></name></person-group><year>2013</year><article-title>The DivJ, CbrA and PleC system controls DivK phosphorylation and symbiosis in Sinorhizobium meliloti</article-title><source>Molecular Microbiology</source><volume>90</volume><fpage>54</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1111/mmi.12347</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puig</surname><given-names>O</given-names></name><name><surname>Caspary</surname><given-names>F</given-names></name><name><surname>Rigaut</surname><given-names>G</given-names></name><name><surname>Rutz</surname><given-names>B</given-names></name><name><surname>Bouveret</surname><given-names>E</given-names></name><name><surname>Bragado-Nilsson</surname><given-names>E</given-names></name><name><surname>Wilm</surname><given-names>M</given-names></name><name><surname>Séraphin</surname><given-names>B</given-names></name></person-group><year>2001</year><article-title>The tandem affinity purification (TAP) method: a general procedure of protein complex purification</article-title><source>Methods</source><volume>24</volume><fpage>218</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1006/meth.2001.1183</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quon</surname><given-names>KC</given-names></name><name><surname>Marczynski</surname><given-names>GT</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>1996</year><article-title>Cell cycle control by an essential bacterial two-component signal transduction protein</article-title><source>Cell</source><volume>84</volume><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80995-2</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quon</surname><given-names>KC</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Domian</surname><given-names>IJ</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name><name><surname>Marczynski</surname><given-names>GT</given-names></name></person-group><year>1998</year><article-title>Negative control of bacterial DNA replication by a cell cycle regulatory protein that binds at the chromosome origin</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>95</volume><fpage>120</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.1.120</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radhakrishnan</surname><given-names>SK</given-names></name><name><surname>Thanbichler</surname><given-names>M</given-names></name><name><surname>Viollier</surname><given-names>PH</given-names></name></person-group><year>2008</year><article-title>The dynamic interplay between a cell fate determinant and a lysozyme homolog drives the asymmetric division cycle of <italic>Caulobacter crescentus</italic></article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>212</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1101/gad.1601808</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radhakrishnan</surname><given-names>SK</given-names></name><name><surname>Pritchard</surname><given-names>S</given-names></name><name><surname>Viollier</surname><given-names>PH</given-names></name></person-group><year>2010</year><article-title>Coupling prokaryotic cell fate and division control with a bifunctional and oscillating oxidoreductase homolog</article-title><source>Developmental Cell</source><volume>18</volume><fpage>90</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.10.024</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raetz</surname><given-names>CR</given-names></name><name><surname>Reynolds</surname><given-names>CM</given-names></name><name><surname>Trent</surname><given-names>MS</given-names></name><name><surname>Bishop</surname><given-names>RE</given-names></name></person-group><year>2007</year><article-title>Lipid A modification systems in gram-negative bacteria</article-title><source>Annual Review of Biochemistry</source><volume>76</volume><fpage>295</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.76.010307.145803</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravenscroft</surname><given-names>N</given-names></name><name><surname>Walker</surname><given-names>SG</given-names></name><name><surname>Dutton</surname><given-names>GG</given-names></name><name><surname>Smit</surname><given-names>J</given-names></name></person-group><year>1991</year><article-title>Identification, isolation, and structural studies of extracellular polysaccharides produced by <italic>Caulobacter crescentus</italic></article-title><source>Journal of Bacteriology</source><volume>173</volume><fpage>5677</fpage><lpage>5684</lpage></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaffner</surname><given-names>TO</given-names></name><name><surname>Hinds</surname><given-names>J</given-names></name><name><surname>Gould</surname><given-names>KA</given-names></name><name><surname>Wüthrich</surname><given-names>D</given-names></name><name><surname>Bruggmann</surname><given-names>R</given-names></name><name><surname>Küffer</surname><given-names>M</given-names></name><name><surname>Mühlemann</surname><given-names>K</given-names></name><name><surname>Hilty</surname><given-names>M</given-names></name><name><surname>Hathaway</surname><given-names>LJ</given-names></name></person-group><year>2014</year><article-title>A point mutation in <italic>cpsE</italic> renders <italic>Streptococcus pneumoniae</italic> nonencapsulated and enhances its growth, adherence and competence</article-title><source>BMC Microbiology</source><volume>14</volume><fpage>210</fpage><pub-id pub-id-type="doi">10.1186/s12866-014-0210-x</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>MC</given-names></name><name><surname>Exley</surname><given-names>RM</given-names></name><name><surname>Ram</surname><given-names>S</given-names></name><name><surname>Sim</surname><given-names>RB</given-names></name><name><surname>Tang</surname><given-names>CM</given-names></name></person-group><year>2007</year><article-title>Interactions between <italic>Neisseria meningitidis</italic> and the complement system</article-title><source>Trends in Microbiology</source><volume>15</volume><fpage>233</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2007.03.005</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seitz</surname><given-names>P</given-names></name><name><surname>Blokesch</surname><given-names>M</given-names></name></person-group><year>2013</year><article-title>Cues and regulatory pathways involved in natural competence and transformation in pathogenic and environmental Gram-negative bacteria</article-title><source>FEMS Microbiology Reviews</source><volume>37</volume><fpage>336</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.2012.00353.x</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siam</surname><given-names>R</given-names></name><name><surname>Marczynski</surname><given-names>GT</given-names></name></person-group><year>2000</year><article-title>Cell cycle regulator phosphorylation stimulates two distinct modes of binding at a chromosome replication origin</article-title><source>The EMBO Journal</source><volume>19</volume><fpage>1138</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1093/emboj/19.5.1138</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>R</given-names></name><name><surname>Priefer</surname><given-names>U</given-names></name><name><surname>Puhler</surname><given-names>A</given-names></name></person-group><year>1983</year><article-title>A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria</article-title><source>Nature Biotechnology</source><volume>1</volume><fpage>784</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1038/nbt1183-784</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skerker</surname><given-names>JM</given-names></name><name><surname>Laub</surname><given-names>MT</given-names></name></person-group><year>2004</year><article-title>Cell-cycle progression and the generation of asymmetry in <italic>Caulobacter crescentus</italic></article-title><source>Nature Reviews Microbiology</source><volume>2</volume><fpage>325</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1038/nrmicro864</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sledjeski</surname><given-names>DD</given-names></name><name><surname>Gottesman</surname><given-names>S</given-names></name></person-group><year>1996</year><article-title>Osmotic shock induction of capsule synthesis in <italic>Escherichia coli</italic> K-12</article-title><source>Journal of Bacteriology</source><volume>178</volume><fpage>1204</fpage><lpage>1206</lpage></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sliusarenko</surname><given-names>O</given-names></name><name><surname>Heinritz</surname><given-names>J</given-names></name><name><surname>Emonet</surname><given-names>T</given-names></name><name><surname>Jacobs-Wagner</surname><given-names>C</given-names></name></person-group><year>2011</year><article-title>High-throughput, subpixel precision analysis of bacterial morphogenesis and intracellular spatio-temporal dynamics</article-title><source>Molecular Microbiology</source><volume>80</volume><fpage>612</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07579.x</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>J</given-names></name><name><surname>Dowling</surname><given-names>DN</given-names></name><name><surname>Broughton</surname><given-names>WJ</given-names></name></person-group><year>1988</year><article-title>Cloning of <italic>hemA</italic> from <italic>Rhizobium</italic> sp. NGR234 and symbiotic phenotype of a gene-directed mutant in diverse legume genera</article-title><source>Molecular and General Genetics</source><volume>215</volume><fpage>32</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1007/BF00331299</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>C</given-names></name><name><surname>Reisenauer</surname><given-names>A</given-names></name><name><surname>Wright</surname><given-names>R</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>1996</year><article-title>A cell cycle-regulated bacterial DNA methyltransferase is essential for viability</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>93</volume><fpage>1210</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.3.1210</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>MH</given-names></name><name><surname>Kozdon</surname><given-names>JB</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name><name><surname>McAdams</surname><given-names>HH</given-names></name></person-group><year>2010</year><article-title>An essential transcription factor, SciP, enhances robustness of <italic>Caulobacter</italic> cell cycle regulation</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>107</volume><fpage>18985</fpage><lpage>18990</lpage><pub-id pub-id-type="doi">10.1073/pnas.1014395107</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thanbichler</surname><given-names>M</given-names></name><name><surname>Iniesta</surname><given-names>AA</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>2007</year><article-title>A comprehensive set of plasmids for vanillate- and xylose-inducible gene expression in <italic>Caulobacter crescentus</italic></article-title><source>Nucleic Acids Research</source><volume>35</volume><fpage>e137</fpage><pub-id pub-id-type="doi">10.1093/nar/gkm818</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toh</surname><given-names>E</given-names></name><name><surname>Kurtz</surname><given-names>HD</given-names><suffix>Jnr</suffix></name><name><surname>Brun</surname><given-names>YV</given-names></name></person-group><year>2008</year><article-title>Characterization of the <italic>Caulobacter crescentus</italic> holdfast polysaccharide biosynthesis pathway reveals significant redundancy in the initiating glycosyltransferase and polymerase steps</article-title><source>Journal of Bacteriology</source><volume>190</volume><fpage>7219</fpage><lpage>7231</lpage><pub-id pub-id-type="doi">10.1128/JB.01003-08</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschowri</surname><given-names>N</given-names></name><name><surname>Busse</surname><given-names>S</given-names></name><name><surname>Hengge</surname><given-names>R</given-names></name></person-group><year>2009</year><article-title>The BLUF-EAL protein YcgF acts as a direct anti-repressor in a blue-light response of <italic>Escherichia coli</italic></article-title><source>Genes &amp; Development</source><volume>23</volume><fpage>522</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1101/gad.499409</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>J</given-names></name><name><surname>Messing</surname><given-names>J</given-names></name></person-group><year>1991</year><article-title>New pUC-derived cloning vectors with different selectable markers and DNA replication origins</article-title><source>Gene</source><volume>100</volume><fpage>189</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/0378-1119(91)90365-I</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viollier</surname><given-names>PH</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>2003</year><article-title>A lytic transglycosylase homologue, PleA, is required for the assembly of pili and the flagellum at the <italic>Caulobacter crescentus</italic> cell pole</article-title><source>Molecular Microbiology</source><volume>49</volume><fpage>331</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03576.x</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viollier</surname><given-names>PH</given-names></name><name><surname>Thanbichler</surname><given-names>M</given-names></name><name><surname>McGrath</surname><given-names>PT</given-names></name><name><surname>West</surname><given-names>L</given-names></name><name><surname>Meewan</surname><given-names>M</given-names></name><name><surname>McAdams</surname><given-names>HH</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>2004</year><article-title>Rapid and sequential movement of individual chromosomal loci to specific subcellular locations during bacterial DNA replication</article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>101</volume><fpage>9257</fpage><lpage>9262</lpage><pub-id pub-id-type="doi">10.1073/pnas.0402606101</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viollier</surname><given-names>PH</given-names></name><name><surname>Sternheim</surname><given-names>N</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>2002</year><article-title>A dynamically localized histidine kinase controls the asymmetric distribution of polar pili proteins</article-title><source>The EMBO Journal</source><volume>21</volume><fpage>4420</fpage><lpage>4428</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdf454</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SP</given-names></name><name><surname>Sharma</surname><given-names>PL</given-names></name><name><surname>Schoenlein</surname><given-names>PV</given-names></name><name><surname>Ely</surname><given-names>B</given-names></name></person-group><year>1993</year><article-title>A histidine protein kinase is involved in polar organelle development in <italic>Caulobacter crescentus</italic></article-title><source>Proceedings of the National Academy of Sciences of USA</source><volume>90</volume><fpage>630</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.2.630</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>RT</given-names></name><name><surname>Shapiro</surname><given-names>L</given-names></name></person-group><year>1999</year><article-title>Differential localization of two histidine kinases controlling bacterial cell differentiation</article-title><source>Molecular Cell</source><volume>4</volume><fpage>683</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(00)80379-2</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitfield</surname><given-names>C</given-names></name></person-group><year>2006</year><article-title>Biosynthesis and assembly of capsular polysaccharides in <italic>Escherichia coli</italic></article-title><source>Annual Review of Biochemistry</source><volume>75</volume><fpage>39</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.75.103004.142545</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiedenbeck</surname><given-names>J</given-names></name><name><surname>Cohan</surname><given-names>FM</given-names></name></person-group><year>2011</year><article-title>Origins of bacterial diversity through horizontal genetic transfer and adaptation to new ecological niches</article-title><source>FEMS Microbiology Reviews</source><volume>35</volume><fpage>957</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.2011.00292.x</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>York</surname><given-names>WS</given-names></name><name><surname>Darvill</surname><given-names>AG</given-names></name><name><surname>McNeil</surname><given-names>M</given-names></name><name><surname>Stevenson</surname><given-names>TT</given-names></name><name><surname>Albersheim</surname><given-names>P</given-names></name></person-group><year>1985</year><article-title>Isolation and characterization of plant cell walls and cell-wall components</article-title><source>Methods in Enzymology</source><volume>118</volume><fpage>3</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(86)18062-1</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yother</surname><given-names>J</given-names></name></person-group><year>2011</year><article-title>Capsules of <italic>Streptococcus pneumoniae</italic> and other bacteria: paradigms for polysaccharide biosynthesis and regulation</article-title><source>Annual Review of Microbiology</source><volume>65</volume><fpage>563</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.62.081307.162944</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.03587.035</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Storz</surname><given-names>Gisela</given-names></name><role>Reviewing editor</role><aff><institution>National Institute of Child Health and Human Development</institution>, <country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see <ext-link ext-link-type="uri" xlink:href="http://elifesciences.org/review-process">review process</ext-link>). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.</p></boxed-text><p>Thank you for sending your work entitled “Cell cycle constraints on capsulation and genetic exchange” for consideration at <italic>eLife.</italic> Your article has been favorably evaluated by Vivek Malhotra (Senior editor), a Reviewing editor, and 3 reviewers, one of whom, Ry Young, has agreed to reveal his identity (the other 2 remain anonymous).</p><p>The Reviewing editor and the other reviewers had a vigorous discussion of the implications of your findings before reaching the decision to consider your manuscript for publication. The Reviewing editor has assembled the following comments to help you prepare a revised submission.</p><p>In this paper, Ardissone et al. investigate the molecular basis of the cell cycle switch in cellular buoyancy in Caulobacter crescentus and doing so, demonstrate that it is linked to cell capsulation and its control during the cell cycle. Specifically, the authors show that the expression of HvyA, a newly identified negative regulator of capsulation is both under tight transcriptional and translational cell cycle control to become cleared when the cells enter the S-phase, allowing the capsulation of a particular cell type. This ensures a cell-specific protection against phage infections and potentially other environmental insults. The regulatory mechanism has been genetically dissected and shown to involve known cell cycle regulators MucR1/2, SciP, CtrA and a still elusive factor X. This regulation or at least the MucR part may be conserved in other alphas. HvyA inhibits capsule formation, but its mode of action, which appears to be conserved in other alpha proteobacteria, remains unknown. Overall, the experiments are high quality and the conclusions are justified.</p><p>However, all reviewers agree the following modifications are critical:</p><p>1) The text needs to be condensed and revised to make the paper easier to read. In addition, the discussion that capsule was selected for phage depredation should be eliminated. Instead, the authors should discuss other possible benefits of the capsule and the observed regulation.</p><p>2) Since “seeing is believing”, the authors should image the capsule at the surface of the stalk (possibly by EM) in both wild type and mutant strains.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.03587.036</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>The revised manuscript features the following editorial and experimental amendments.</p><p>1) We streamlined the text, with a shortened Introduction and Discussion as recommended.</p><p>2) We included cytological experiments providing compelling evidence that Caulobacter S-phase cells are encased in a polysaccharidic capsule.</p><p>2a) First, negative staining fluorescence microscopy revealed a thick layer that excludes FITC-labeled dextran from the delta-<italic>hvyA</italic> (capsulated) mutant versus the delta-<italic>CCNA00163</italic> (non-capsulated) mutant in which a component of the export machinery has been inactivated. These fluorescence images and quantification are show in the new <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p><p>2b) Second, atomic force microscopy of the same strains revealed a smoother surface on delta-<italic>CCNA00163</italic> cells compared to delta-<italic>hvyA</italic> cells (new <xref ref-type="fig" rid="fig5">Figure 5</xref>). The difference in surface roughness is consistent with the biophysical properties expected for an amorphous layer of polysaccharides.</p><p>2c) Third, we used live cell fluorescence microscopy of cells expressing a different component of the capsule export machinery (CCNA00162, CCNA00163 and CCNA00168) as full-length translational fusion to mCherry to find that the mCherry-derived fluorescence emanates through the cell, suggesting that the export machinery (and thus the exported capsule) is not localized to specific subcellular site. These images are shown in Figure 4–figure supplement 1).</p><p>2d) Lastly, negative stain fluorescence microscopy of Caulobacter (NA1000) WT cells using FITC-dextran revealed that S-phase (stalked and/or constricted) cells exclude the dye. Cells that do not exclude the dye are stalkless and non-constricted (and thus in G1-phase). This important result that reinforces our conclusion that G1-cells are non-capsulated is also shown in the new <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p></body></sub-article></article>